rearrangement	amino_acid	frame_type	rearrangement_type	templates	reads	frequency	productive_frequency	cdr3_length	v_family	v_gene	v_allele	d_family	d_gene	d_allele	j_family	j_gene	j_allele	v_deletions	d5_deletions	d3_deletions	j_deletions	n2_insertions	n1_insertions	v_index	n1_index	n2_index	d_index	j_index	v_family_ties	v_gene_ties	v_allele_ties	d_family_ties	d_gene_ties	d_allele_ties	j_family_ties	j_gene_ties	j_allele_ties	sequence_tags	v_shm_count	v_shm_indexes	antibody	bio_identity	v_resolved	d_resolved	j_resolved	sample_name	species	locus	product_subtype	kit_pool	sku	test_name	sample_catalog_tags	sample_rich_tags	sample_rich_tags_json	kit_control	total_templates	productive_templates	outofframe_templates	stop_templates	dj_templates	total_rearrangements	productive_rearrangements	outofframe_rearrangements	stop_rearrangements	dj_rearrangements	total_reads	total_productive_reads	total_outofframe_reads	total_stop_reads	total_dj_reads	productive_clonality	productive_entropy	sample_clonality	sample_entropy	sample_amount_ng	sample_cells_mass_estimate	fraction_productive_of_cells_mass_estimate	sample_cells	fraction_productive_of_cells	max_productive_frequency	max_frequency	counting_method	primer_set	sequence_result_status	release_date	upload_date	sample_tags	fraction_productive	order_name	kit_id	total_t_cells	total_templates_agg
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGCGGAGGACCTGGAAACACCATATATTTTGGAGAG	CASSGGPGNTIYF	In	VDJ	1	13	7.046070460704607E-4	9.098544232922733E-4	39	TCRBV09	TCRBV09-01					TCRBJ01	TCRBJ01-03	01	3	1	7	2	2	0	23	36	-1	38	42			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	CASSGGPGNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01		TCRBJ01-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAGCAACTACGGGGAAACACCATATATTTTGGAGAG	CASSEQLRGNTIYF	In	VDJ	1	22	0.0011924119241192412	0.001539753639417693	42	TCRBV09	TCRBV09-01		TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	3	9	4	6	3	23	34	44	40	47			01,02			01,02							Vb 1	CASSEQLRGNTIYF+TCRBV09-01+TCRBJ01-03	TCRBV09-01	TCRBD02-01	TCRBJ01-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAAGAGGGGGAGTTCCTATAATTCACCCCTCCACTTTGGGAAC	CASKRGSSYNSPLHF	In	VDJ	1	25	0.0013550135501355014	0.0017497200447928333	45	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	5	1	1	2	3	23	33	41	35	44			01,02										Vb 1	CASKRGSSYNSPLHF+TCRBV09-01+TCRBJ01-06	TCRBV09-01	TCRBD01-01*01	TCRBJ01-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGTCGAGAGGGGATTCCCTATCTTGTAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	26	0.0014092140921409214		52	TCRBV09	TCRBV09-01					TCRBJ02	TCRBJ02-01	01	5	5	2	7	7	14	23	34	46	41	60			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 1	X+TCRBV09-01+TCRBJ02-01	TCRBV09-01		TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TGGGGGACTCAGCTTTGTATTTCTGTGCCAGCAGTGAATGGCAGGGGAACGAGCAGTACTTCGGGCCG	CASSEWQGNEQYF	In	VDJ	1	33	0.0017886178861788618	0.0023096304591265398	39	TCRBV09	TCRBV09-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	4	2	5	7	1	23	34	47	41	48			01,02										Vb 1	CASSEWQGNEQYF+TCRBV09-01+TCRBJ02-07	TCRBV09-01	TCRBD01-01*01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCGGCCATGTATCTCTGTGCCAGCAGCCAACCCGTTCGGGACTAGCTCAATGAGCAGTTCTTCGGGCCA	CASSQPVRD*LNEQFF	Stop	VDJ	1	21	0.0011382113821138211		48	TCRBV11	TCRBV11-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	7	6	10	1	19	31	50	41	51						01,02								CASSQPVRD*LNEQFF+TCRBV11-01+TCRBJ02-01	TCRBV11-01*01	TCRBD02-01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGAGCGAATTAAGGGGTTTACTCTGGAAACACCATATATTTTGGAGAG		Out	VDJ	1	11	5.962059620596206E-4		56	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	0	5	2	0	8	4	25	42	55	50	59													Vb 16	X+TCRBV14-01+TCRBJ01-03	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCCTTTGAAAGACAGGGACAGGGGCTACGAGCAGTACTTCGGGCCG	CASSPLKDRDRGYEQYF	In	VDJ	1	11	5.962059620596206E-4	7.698768197088465E-4	51	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	0	2	3	12	0	29	42	-1	54	64													Vb 16	CASSPLKDRDRGYEQYF+TCRBV14-01+TCRBJ02-07	TCRBV14-01*01	TCRBD01-01*01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGGGGGGAGTGGGAGGCGCTTTCTTTGGACAA	CASSQGGVGGAFF	In	VDJ	1	13	7.046070460704607E-4	9.098544232922733E-4	39	TCRBV14	TCRBV14-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	9	1	11	0	10	29	-1	49	43	59						01,02							Vb 16	CASSQGGVGGAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD02-01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAAGCTTGGGGCCCTGAAGCTTTCTTTGGACAA	CASSQAWGPEAFF	In	VDJ	1	17	9.214092140921409E-4	0.0011898096304591265	39	TCRBV14	TCRBV14-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	7	0	6	3	1	29	45	53	48	54													Vb 16	CASSQAWGPEAFF+TCRBV14-01+TCRBJ01-01	TCRBV14-01*01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCAGGGGGAGTGTATGGCTACACCTTCGGTTCG		Out	VDJ	1	22	0.0011924119241192412		38	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-02	01	3	6	1	5	0	4	29	-1	48	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ01-02	TCRBV14-01*01		TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAGAACTGGAGGATTCTGGAGTTTATTTCTGTGCCAGCAGCCTCGGGGCTTTAAAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	2	56	0.003035230352303523		43	TCRBV14	TCRBV14-01	01				TCRBJ01	TCRBJ01-05	01	4	7	0	4	2	5	29	42	49	44	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 16	X+TCRBV14-01+TCRBJ01-05	TCRBV14-01*01		TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAACAGCGTGGTATCAGGGGGAGGCTATGGCTACACCTTCGGTTCG	CANSVVSGGGYGYTF	In	VDJ	1	11	5.962059620596206E-4	7.698768197088465E-4	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	1	4	7	3	24	36	50	43	53														CANSVVSGGGYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAAGGGGTGGAACACTGAAGCTTTCTTTGGACAA	CASKGWNTEAFF	In	VDJ	1	11	5.962059620596206E-4	7.698768197088465E-4	36	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	5	2	1	3	2	24	31	39	34	41														CASKGWNTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGCGACAGGATACACCGGGGAGCTGTTTTTTGGAGAA	CASSATGYTGELFF	In	VDJ	1	11	5.962059620596206E-4	7.698768197088465E-4	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	2	4	3	2	2	24	36	44	38	46														CASSATGYTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCGGCCCGATGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	11	5.962059620596206E-4		44	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-02	01	6	2	7	4	14	0	24	35	-1	49	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01		TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCAAAGGGCAGGGTTGGGGACAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	12	6.504065040650406E-4		49	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	4	3	3	2	7	24	40	47	42	54														X+TCRBV21-or09_02+TCRBJ02-04	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCTGGACCTGTCTGGAAACACCATATATTTTGGAGAG	CASSLDLSGNTIYF	In	VDJ	1	12	6.504065040650406E-4	8.398656215005599E-4	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-03	01	5	1	7	1	2	3	24	36	42	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLDLSGNTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01		TCRBJ01-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCAACAGCGGCACTATGGCTACACCTTCGGTTCG	CASSQQRHYGYTF	In	VDJ	1	13	7.046070460704607E-4	9.098544232922733E-4	39	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	6	5	3	5	1	24	35	45	40	46						01,02								CASSQQRHYGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCAAGGTCCTTACGAGCAGTACTTCGGGCCG	CASSQGPYEQYF	In	VDJ	1	14	7.588075880758808E-4	9.798432250839866E-4	36	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	1	4	10	4	3	0	24	40	-1	43	45						01,02								CASSQGPYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCTGTGGTACTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	14	7.588075880758808E-4		37	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-06	01	5	0	10	10	5	3	24	36	43	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-06	TCRBV21-or09_02*01		TCRBJ01-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCTTATGTCTGTGGAGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	15	8.130081300813008E-4		38	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	10	10	2	5	12	0	24	31	-1	43	47														X+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTTGAAAACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSFENSYNEQFF	In	VDJ	1	17	9.214092140921409E-4	0.0011898096304591265	42	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-01	01	6	2	8	0	4	3	24	35	41	39	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFENSYNEQFF+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01		TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTATCTCCGGATGCGCCAGATACGCAGTATTTTGGCCCA	CASSVSPDAPDTQYF	In	VDJ	1	18	9.75609756097561E-4	0.0012597984322508398	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-03	01	5	1	8	4	8	5	24	36	47	44	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVSPDAPDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01		TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGAGTTGTCTACACAATTCGCACTGAAGCTTTCTTTGGACAA	CASRVVYTIRTEAFF	In	VDJ	1	20	0.001084010840108401	0.0013997760358342665	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	6	3	6	4	8	7	24	35	46	43	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASRVVYTIRTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGTGAACAACGGCCGCACAGATACGCAGTATTTTGGCCCA	CASSVVNNGRTDTQYF	In	VDJ	1	20	0.001084010840108401	0.0013997760358342665	48	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-03	01	5	3	6	1	7	6	24	36	46	43	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVVNNGRTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01		TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGTTACAGGGAGATGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	21	0.0011382113821138211		47	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	3	3	7	5	24	36	49	43	54														X+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCATGGGGTATGGGAATCAGCCCCAGCATTTTGGTGAT	CASMGYGNQPQHF	In	VDJ	1	23	0.0012466124661246612	0.0016097424412094064	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-05	01	10	6	2	4	4	6	24	31	39	35	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASMGYGNQPQHF+TCRBV21-or09_02+TCRBJ01-05	TCRBV21-or09_02*01		TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGATCCCCAGAGTTACACTGAAGCTTTCTTTGGACAA	CASSVDPQSYTEAFF	In	VDJ	1	25	0.0013550135501355014	0.0017497200447928333	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-01	01	5	4	5	3	9	4	24	36	48	45	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVDPQSYTEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01		TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGTGTCGGTAGGGACCCAGTACTTCGGGCCA	CASSVVSVGTQYF	In	VDJ	1	27	0.0014634146341463415	0.0018896976483762599	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-05	01	5	5	4	7	11	0	24	36	-1	47	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVVSVGTQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01		TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTGAAATGCGGGCACCGTCCTACGAGCAGTACTTCGGGCCG	CASSEMRAPSYEQYF	In	VDJ	1	28	0.0015176151761517615	0.001959686450167973	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	7	4	1	6	5	24	35	46	41	51						01,02								CASSEMRAPSYEQYF+TCRBV21-or09_02+TCRBJ02-07	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTAAACCGCAGGGCCGGAGATACGCAGTATTTTGGCCCA	CASSLNRRAGDTQYF	In	VDJ	1	29	0.0015718157181571816	0.0020296752519596865	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	4	3	5	9	4	24	35	49	44	53														CASSLNRRAGDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCATGGGGGAGACAGTCGGAAAAGAGACCCAGTACTTCGGGCCA	CASMGETVGKETQYF	In	VDJ	1	30	0.0016260162601626016	0.0020996640537514	45	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-05	01	10	2	5	3	10	6	24	31	46	41	52				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASMGETVGKETQYF+TCRBV21-or09_02+TCRBJ02-05	TCRBV21-or09_02*01		TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTGCGTCCGGGACACATTAACACCGGGGAGCTGTTTTTTGGAGAA	CASSVRPGHINTGELFF	In	VDJ	1	33	0.0017886178861788618	0.0023096304591265398	51	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	6	2	8	4	24	36	50	44	54														CASSVRPGHINTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCGTAGGACAGGGGAGTCATGGCTACACCTTCGGTTCG	CASSVGQGSHGYTF	In	VDJ	1	39	0.002113821138211382	0.0027295632698768196	42	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	2	6	3	4	24	36	48	39	52														CASSVGQGSHGYTF+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTCAAACGATGCTACAAGGTGCATAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	40	0.002168021680216802		52	TCRBV21	TCRBV21-or09_02	01				TCRBJ01	TCRBJ01-04	01	6	3	6	4	12	7	24	35	50	47	57				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV21-or09_02+TCRBJ01-04	TCRBV21-or09_02*01		TCRBJ01-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGGCGTTCTACAAAAGACTGAGTGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	42	0.0022764227642276423		55	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	2	10	4	13	11	24	35	52	48	63						01,02								X+TCRBV21-or09_02+TCRBJ01-02	TCRBV21-or09_02*01	TCRBD02-01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTGGACAGTGTTCTCTGGGGACACCATATATTTTGGAGAG	CASSWTVFSGDTIYF	In	VDJ	1	47	0.0025474254742547425	0.003289473684210526	45	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	1	5	8	2	12	24	35	43	37	55														CASSWTVFSGDTIYF+TCRBV21-or09_02+TCRBJ01-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ01-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGTTTTCGGCAGGGGAGGGCTGAAGCTTTCTTTGGACAA	CASSFRQGRAEAFF	In	VDJ	1	49	0.0026558265582655827	0.0034294512877939528	42	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	9	0	6	10	0	24	35	-1	45	52														CASSFRQGRAEAFF+TCRBV21-or09_02+TCRBJ01-01	TCRBV21-or09_02*01	TCRBD02-01*02	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTCGCTAGGAGGGACAGGGTCCGTTACGCAGTATTTTGGCCCA	CASSSLGGTGSVTQYF	In	VDJ	2	57	0.003089430894308943	0.003989361702127659	48	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	0	3	8	9	5	24	36	54	45	59														CASSSLGGTGSVTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCACGAACTCGGGGGGCCATAATTCACCCCTCCACTTTGGGAAC	CASTNSGGHNSPLHF	In	VDJ	2	67	0.0036314363143631436	0.004689249720044793	45	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-06	01	10	8	1	5	9	2	24	31	47	40	49														CASTNSGGHNSPLHF+TCRBV21-or09_02+TCRBJ01-06	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ01-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCTTTCGGGCAGGGTTTGAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	4	134	0.007262872628726287		46	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	4	3	5	7	5	24	36	48	43	53														X+TCRBV21-or09_02+TCRBJ02-01	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCCCCGAAGCACAGATACGCAGTATTTTGGCCCA	CASSPRSTDTQYF	In	VDJ	4	150	0.008130081300813009	0.010498320268757	39	TCRBV21	TCRBV21-or09_02	01				TCRBJ02	TCRBJ02-03	01	5	2	8	0	4	0	24	36	-1	40	42				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPRSTDTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01		TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAACCAGGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASNQGNTGELFF	In	VDJ	4	155	0.008401084010840108	0.010848264277715566	39	TCRBV21	TCRBV21-or09_02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	10	4	3	1	5	0	24	31	-1	36	41														CASNQGNTGELFF+TCRBV21-or09_02+TCRBJ02-02	TCRBV21-or09_02*01	TCRBD01-01*01	TCRBJ02-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCAGGAGACACAGCACGGTATTTCTGTGCCAGCAGCCACCCCGGGGGGGCCAGGGCAGATACGCAGTATTTTGGCCCA	CASSHPGGARADTQYF	In	VDJ	4	156	0.008455284552845528	0.010918253079507279	48	TCRBV21	TCRBV21-or09_02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	8	0	4	5	6	24	36	49	41	55														CASSHPGGARADTQYF+TCRBV21-or09_02+TCRBJ02-03	TCRBV21-or09_02*01	TCRBD02-01*01	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCCCCAACCCGGGGGGATCCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPNPGGSSGANVLTF	In	VDJ	1	11	5.962059620596206E-4	7.698768197088465E-4	54	TCRBV07	TCRBV07-06	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-06	01	5	8	1	0	7	3	18	30	44	37	47														CASSPNPGGSSGANVLTF+TCRBV07-06+TCRBJ02-06	TCRBV07-06*01	TCRBD02-01*01	TCRBJ02-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTGAGGCAGGGGGCACAGCTAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	15	8.130081300813008E-4		50	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	0	0	4	4	18	32	44	36	48														X+TCRBV07-06+TCRBJ01-02	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTTGGGGCAGGGGAGAGTAACTATGGCTACACCTTCGGTTCG	CASSFGAGESNYGYTF	In	VDJ	1	22	0.0011924119241192412	0.001539753639417693	48	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	3	4	2	1	5	4	18	32	43	37	47														CASSFGAGESNYGYTF+TCRBV07-06+TCRBJ01-02	TCRBV07-06*01	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTACGTCGAGACAGGGGAAGGCTACGAGCAGTACTTCGGGCCG	CASSYVETGEGYEQYF	In	VDJ	1	29	0.0015718157181571816	0.0020296752519596865	48	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	2	2	3	7	4	18	31	46	38	50														CASSYVETGEGYEQYF+TCRBV07-06+TCRBJ02-07	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCATGTATCGCTGTGCCAGCAGCTTAGCCGGGACAGGGCACACAGATACGCAGTATTTTGGCCCA	CASSLAGTGHTDTQYF	In	VDJ	1	30	0.0016260162601626016	0.0020996640537514	48	TCRBV07	TCRBV07-06	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	0	0	3	2	1	2	18	35	45	36	47														CASSLAGTGHTDTQYF+TCRBV07-06+TCRBJ02-03	TCRBV07-06*01	TCRBD01-01*01	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTACTAGCGGGGGGCAGGAATGAGCAGTTCTTCGGGCCA	CASSLLAGGRNEQFF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	45	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	4	1	7	0	4	19	-1	45	34	49														CASSLLAGGRNEQFF+TCRBV07-05+TCRBJ02-01	TCRBV07-05*01	TCRBD02-01*01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGCGGGGGGGCCGTTGGACATTCAGTACTTCGGCGCC	CASSLAGGPLDIQYF	In	VDJ	1	11	5.962059620596206E-4	7.698768197088465E-4	45	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	0	8	0	8	0	7	19	-1	43	35	50														CASSLAGGPLDIQYF+TCRBV07-05+TCRBJ02-04	TCRBV07-05*01	TCRBD02-01*01	TCRBJ02-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCGAGAGAGCGTCGGGGGCCCGAGGAGATACGCAGTATTTTGGCCCA	CASSERASGARGDTQYF	In	VDJ	1	17	9.214092140921409E-4	0.0011898096304591265	51	TCRBV07	TCRBV07-05	01				TCRBJ02	TCRBJ02-03	01	4	6	0	5	11	6	19	31	48	42	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSERASGARGDTQYF+TCRBV07-05+TCRBJ02-03	TCRBV07-05*01		TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGTCTACAGGGTTGGGACACTGAAGCTTTCTTTGGACAA	CASSLQGWDTEAFF	In	VDJ	1	23	0.0012466124661246612	0.0016097424412094064	42	TCRBV07	TCRBV07-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	8	3	3	3	6	5	19	27	39	33	44														CASSLQGWDTEAFF+TCRBV07-05+TCRBJ01-01	TCRBV07-05*01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTCAGCCGACTAGCGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	31	0.0016802168021680217		46	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	2	2	7	1	5	0	19	33	-1	38	45						01,02								X+TCRBV07-05+TCRBJ02-03	TCRBV07-05*01	TCRBD02-01	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTTAGTGTTCTCCCCGGCGGATCAGCCCCAGCATTTTGGTGAT	CASSLVFSPADQPQHF	In	VDJ	1	36	0.001951219512195122	0.0025195968645016797	48	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	0	7	5	5	11	0	19	35	-1	46	50						01,02								CASSLVFSPADQPQHF+TCRBV07-05+TCRBJ01-05	TCRBV07-05*01	TCRBD02-01	TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCACCGAAAGGGAGGAATGGGGATGGCTACACCTTCGGTTCG		Out	VDJ	1	49	0.0026558265582655827		43	TCRBV07	TCRBV07-05	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	8	9	1	6	8	7	19	27	41	35	48														X+TCRBV07-05+TCRBJ01-02	TCRBV07-05*01	TCRBD02-01*02	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCACCCTACAGGGGGCGTACAATGAGCAGTTCTTCGGGCCA	CASTLQGAYNEQFF	In	VDJ	1	16	8.672086720867209E-4	0.0011198208286674132	42	TCRBV07	TCRBV07-04	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	7	3	0	4	4	1	22	32	45	36	46														CASTLQGAYNEQFF+TCRBV07-04+TCRBJ02-01	TCRBV07-04*01	TCRBD01-01*01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGGGGACTCAGCTGTGTATCTCTGTGCCAGCAGCCTGGGGCGGAAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	17	9.214092140921409E-4		38	TCRBV07	TCRBV07-04	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	7	0	5	2	3	22	34	41	36	44														X+TCRBV07-04+TCRBJ02-03	TCRBV07-04*01	TCRBD01-01*01	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGCCTACCTTTACAGTTTGTCGTGGATAATTCACCCCTCCACTTTGGGAAC	CAWSLPLQFVVDNSPLHF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	54	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	3	5	5	9	10	26	37	50	46	60			unresolved										Vb 20	CAWSLPLQFVVDNSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTACAGCTCAGTCCCAGCATTTTGGTGAT	CAWSTAQSQHF	In	VDJ	1	12	6.504065040650406E-4	8.398656215005599E-4	33	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	3	5	11	0	6	26	-1	42	38	48			unresolved										Vb 20	CAWSTAQSQHF+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAACGGAGCCCAGAGCATTTATCGACCGGGAAACACCATATATTTTGGAGAG	CAWNGAQSIYRPGNTIYF	In	VDJ	1	14	7.588075880758808E-4	9.798432250839866E-4	54	TCRBV30	TCRBV30-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	4	10	2	4	2	20	26	36	42	38	62			unresolved										Vb 20	CAWNGAQSIYRPGNTIYF+TCRBV30-01+TCRBJ01-03	TCRBV30-01*01	TCRBD02-01*02	TCRBJ01-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAGGTTTCGAGGGGCAGGGAACTTTCTTTGGACAA	CAWSVGFEGQGTFF	In	VDJ	1	17	9.214092140921409E-4	0.0011898096304591265	42	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	0	4	3	12	13	2	26	40	58	53	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSVGFEGQGTFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGGGAAGGTTTCAGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	19	0.001029810298102981		41	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	4	3	9	0	26	37	-1	46	50			unresolved										Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGAGTAGACAGGAAGAAAGCTTTCTTTGGACAA	CAWRVDRKKAFF	In	VDJ	1	19	0.001029810298102981	0.0013297872340425532	36	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	4	9	4	4	26	37	47	41	51													Vb 20	CAWRVDRKKAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACTTGCGGAGGGAAGCTTTCTTTGGACAA		Out	VDJ	1	22	0.0011924119241192412		37	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	0	10	1	8	6	0	26	40	-1	46	51													Vb 20	X+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD02-01*02	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAACCGGGACAGAAGCTTTCTTTGGACAA	CAWSVTGTEAFF	In	VDJ	1	25	0.0013550135501355014	0.0017497200447928333	36	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	6	8	4	0	26	40	-1	44	50													Vb 20	CAWSVTGTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTCTCGTCTGGAGGGGGCCTTGGCAATCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	27	0.0014634146341463415		52	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	5	0	2	9	4	26	38	54	47	58													Vb 20	X+TCRBV30-01+TCRBJ01-05	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGATACGGGCGGACCTCGATTCACCCCTCCACTTTGGGAAC	CAWIRADLDSPLHF	In	VDJ	1	35	0.001897018970189702	0.0024496080627099664	42	TCRBV30	TCRBV30-01	02				TCRBJ01	TCRBJ01-06	01	4	1	7	8	7	4	26	36	47	43	51			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWIRADLDSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*02		TCRBJ01-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTAATAAACAGGGATTCACCCCTCCACTTTGGGAAC	CAWSVINRDSPLHF	In	VDJ	1	37	0.002005420054200542	0.002589585666293393	42	TCRBV30	TCRBV30-01	02	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	0	3	3	8	5	0	26	40	-1	45	51													Vb 20	CAWSVINRDSPLHF+TCRBV30-01+TCRBJ01-06	TCRBV30-01*02	TCRBD01-01*01	TCRBJ01-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCGGAATCCCGGGACAGGGTTTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CAGIPGQGFSGANVLTF	In	VDJ	1	40	0.002168021680216802	0.002799552071668533	51	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	8	0	3	0	8	3	26	32	49	40	52													Vb 20	CAGIPGQGFSGANVLTF+TCRBV30-01+TCRBJ02-06	TCRBV30-01*01	TCRBD01-01*01	TCRBJ02-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTAGCCCGGGGACAGGGGAGGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	45	0.0024390243902439024		49	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	0	2	2	6	3	26	38	54	44	57													Vb 20	X+TCRBV30-01+TCRBJ01-02	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTTTCTGGACGAGCACTGAAGCTTTCTTTGGACAA	CAWSFWTSTEAFF	In	VDJ	2	55	0.002981029810298103	0.003849384098544233	39	TCRBV30	TCRBV30-01	01				TCRBJ01	TCRBJ01-01	01	2	1	7	4	4	3	26	38	46	42	49			unresolved	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 20	CAWSFWTSTEAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01		TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TYCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGAGTGTACTGGGGAGGGAAAACTACGAGCAGTACTTCGGGCCG	CAWSVLGRENYEQYF	In	VDJ	2	80	0.004336043360433604	0.005599104143337066	45	TCRBV30	TCRBV30-01	02	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	0	9	0	3	4	4	26	40	51	44	55			unresolved										Vb 20	CAWSVLGRENYEQYF+TCRBV30-01+TCRBJ02-07	TCRBV30-01*02	TCRBD02-01*02	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TTCTCAGTGACTCTGGCTTCTATCTCTGTGCCTGGGTGGGGACAGGGATCGCTTTCTTTGGACAA	CAWVGTGIAFF	In	VDJ	3	102	0.0055284552845528455	0.00713885778275476	33	TCRBV30	TCRBV30-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	0	3	11	3	3	26	35	47	38	50													Vb 20	CAWVGTGIAFF+TCRBV30-01+TCRBJ01-01	TCRBV30-01*01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGTTTCGTGGGGGGCAACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CTSSFVGGNSGANVLTF	In	VDJ	1	11	5.962059620596206E-4	7.698768197088465E-4	51	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-06	01	6	6	0	0	7	2	23	34	47	41	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CTSSFVGGNSGANVLTF+TCRBV01-01+TCRBJ02-06	TCRBV01-01*01		TCRBJ02-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGGGAATCTGAACTATGGCTACACCTTCGGTTCG	CASSQGNLNYGYTF	In	VDJ	1	15	8.130081300813008E-4	0.0010498320268757	42	TCRBV01	TCRBV01-01	01				TCRBJ01	TCRBJ01-02	01	1	1	8	2	0	5	23	-1	42	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQGNLNYGYTF+TCRBV01-01+TCRBJ01-02	TCRBV01-01*01		TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAACGGACAGCCGAGTCTCTGGAAACACCATATATTTTGGAGAG	CASSQTDSRVSGNTIYF	In	VDJ	1	17	9.214092140921409E-4	0.0011898096304591265	51	TCRBV01	TCRBV01-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	1	5	0	2	6	23	38	46	40	52														CASSQTDSRVSGNTIYF+TCRBV01-01+TCRBJ01-03	TCRBV01-01*01	TCRBD01-01*01	TCRBJ01-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCCCTGGTTGGAACACCAGACCCTCTACGAGCAGTACTTCGGGCCG	CASSPWLEHQTLYEQYF	In	VDJ	1	17	9.214092140921409E-4	0.0011898096304591265	51	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-07	01	4	1	8	3	7	12	23	36	46	43	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPWLEHQTLYEQYF+TCRBV01-01+TCRBJ02-07	TCRBV01-01*01		TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AAGAAGACTCAGCTGCGTATCTCTGCACCAGCAGTTGGGTACGTTTGTGAAGTCGGGCCAACGTCCTGACTTTCGGGGCC	CTSSWVRL*SRANVLTF	Stop	VDJ	1	22	0.0011924119241192412		51	TCRBV01	TCRBV01-01	01				TCRBJ02	TCRBJ02-06	01	6	0	9	5	2	15	23	34	39	36	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CTSSWVRL*SRANVLTF+TCRBV01-01+TCRBJ02-06	TCRBV01-01*01		TCRBJ02-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCGCATATAGCTCTGGAAACACCATATATTTTGGAGAG	CASSAYSSGNTIYF	In	VDJ	1	27	0.0014634146341463415	0.0018896976483762599	42	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	5	8	0	5	0	23	35	-1	40	43						01,02								CASSAYSSGNTIYF+TCRBV01-01+TCRBJ01-03	TCRBV01-01*01	TCRBD02-01	TCRBJ01-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AAGAAGACTCAGCTGCGTATCTCTGCGCCAGCAGCCAAGAACTAGCGGGGGCCCAAGGGGATACGCAGTATTTTGGCCCA	CASSQELAGAQGDTQYF	In	VDJ	1	37	0.002005420054200542	0.002589585666293393	51	TCRBV01	TCRBV01-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	0	3	2	6	0	8	23	-1	51	40	59														CASSQELAGAQGDTQYF+TCRBV01-01+TCRBJ02-03	TCRBV01-01*01	TCRBD02-01*01	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCTCGGGGGGCAACTATGGCTACACCTTCGGTTCG	CASSSSGGNYGYTF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	42	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	8	1	2	3	1	19	32	42	35	43													Vb 5.1	CASSSSGGNYGYTF+TCRBV05-01+TCRBJ01-02	TCRBV05-01*01	TCRBD02-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGGCGTCTAGCAGAGACAATGAGCAGTTCTTCGGGCCA	CASSLASSRDNEQFF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	45	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	4	7	5	3	4	19	35	43	38	47						01,02							Vb 5.1	CASSLASSRDNEQFF+TCRBV05-01+TCRBJ02-01	TCRBV05-01*01	TCRBD02-01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTTACGAGGGGGCGGGGCACAGATACGCAGTATTTTGGCCCA	CASSFTRGRGTDTQYF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	48	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	5	0	1	4	3	19	33	44	37	47													Vb 5.1	CASSFTRGRGTDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD01-01*01	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTGCCTGGGGGGACAGGGGACAATTCACCCCTCCACTTTGGGAAC	CASSLPGGTGDNSPLHF	In	VDJ	1	12	6.504065040650406E-4	8.398656215005599E-4	51	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	1	0	2	7	6	2	19	34	50	40	52													Vb 5.1	CASSLPGGTGDNSPLHF+TCRBV05-01+TCRBJ01-06	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTCCTTTGGGCAAGGTAGAGGGGATACGCAGTATTTTGGCCCA	CASSSFGQGRGDTQYF	In	VDJ	1	15	8.130081300813008E-4	0.0010498320268757	48	TCRBV05	TCRBV05-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	3	11	0	6	15	0	19	32	-1	47	52													Vb 5.1	CASSSFGQGRGDTQYF+TCRBV05-01+TCRBJ02-03	TCRBV05-01*01	TCRBD02-01*02	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTTCGGCGCAGGGTCTGCACCGCAGCATTTTGGTGAT	CASSFGAGSAPQHF	In	VDJ	1	21	0.0011382113821138211	0.0014697648376259798	42	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	2	4	3	13	5	9	19	33	43	38	52													Vb 5.1	CASSFGAGSAPQHF+TCRBV05-01+TCRBJ01-05	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCGGCCCTTTATCTTTGCGCCAGCAGCTGGGCAGGGAAGGACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	43	0.0023306233062330623		40	TCRBV05	TCRBV05-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	3	5	3	4	19	32	40	35	44													Vb 5.1	X+TCRBV05-01+TCRBJ01-01	TCRBV05-01*01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GAGGGACTCAGCCGTGTATCTCTACACCAGCAGCCCTGGGACTAGCGGGGGTTTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	25	0.0013550135501355014		44	TCRBV17	TCRBV17-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	10	0	2	9	11	2	22	26	51	37	53														X+TCRBV17-01+TCRBJ02-01	TCRBV17-01*01	TCRBD02-01*01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCTAAGGGAGGACATCTCAGCATTTTGGTGAT		Out	VDJ	1	10	5.420054200542005E-4		38	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-05	01	6	9	1	13	6	6	25	36	48	42	54													Vb 3	X+TCRBV28-01+TCRBJ01-05	TCRBV28-01*01	TCRBD02-01*02	TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTCGGAGACAGGGCGAATGAAAAACTGTTTTTTGGCAGT	CASSFGDRANEKLFF	In	VDJ	1	17	9.214092140921409E-4	0.0011898096304591265	45	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	2	3	5	4	2	25	39	50	43	52													Vb 3	CASSFGDRANEKLFF+TCRBV28-01+TCRBJ01-04	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCTGAACGGGTTCGGGACAGCCCTCCGTGAAGCTTTCTTTGGACAA		Out	VDJ	1	22	0.0011924119241192412		50	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	5	7	12	7	25	36	55	48	62													Vb 3	X+TCRBV28-01+TCRBJ01-01	TCRBV28-01*01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTGGACCTCTCTTGACACAAAGTCGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	26	0.0014092140921409214		55	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-06	01	4	1	7	5	0	18	25	-1	42	38	60				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	X+TCRBV28-01+TCRBJ02-06	TCRBV28-01*01		TCRBJ02-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAACTTTAGGCTTTCGGAGACCCAGTACTTCGGGCCA	CASNFRLSETQYF	In	VDJ	1	31	0.0016802168021680217	0.002169652855543113	39	TCRBV28	TCRBV28-01	01				TCRBJ02	TCRBJ02-05	01	7	5	4	5	5	6	25	35	43	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 3	CASNFRLSETQYF+TCRBV28-01+TCRBJ02-05	TCRBV28-01*01		TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGCCCCTGGTCGGGGAAGGGGGCAGATACGCAGTATTTTGGCCCA	CASSPWSGKGADTQYF	In	VDJ	1	40	0.002168021680216802	0.002799552071668533	48	TCRBV28	TCRBV28-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	5	1	4	14	0	25	36	-1	50	56													Vb 3	CASSPWSGKGADTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD01-01*01	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCAGTTTTCAGATCGGGTTCGGCGAGCAGTACTTCGGGCCG	CASSFQIGFGEQYF	In	VDJ	1	51	0.0027642276422764228	0.00356942889137738	42	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	8	4	6	6	5	25	39	49	45	54						01,02							Vb 3	CASSFQIGFGEQYF+TCRBV28-01+TCRBJ02-07	TCRBV28-01*01	TCRBD02-01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CACCAACCAGACATCTATGTACCTCTGTGCCAGCTCCTCCCTCGGGAGACTGAGCACAGATACGCAGTATTTTGGCCCA	CASSSLGRLSTDTQYF	In	VDJ	24	875	0.04742547425474255	0.06124020156774916	48	TCRBV28	TCRBV28-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	8	8	2	0	8	4	25	34	48	42	52													Vb 3	CASSSLGRLSTDTQYF+TCRBV28-01+TCRBJ02-03	TCRBV28-01*01	TCRBD02-01*02	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCATCCCCGAGAGCTGATCAACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	20	0.001084010840108401		41	TCRBV12	TCRBV12-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	12	6	7	5	10	6	18	23	36	33	42						01,02								X+TCRBV12-02+TCRBJ02-01	TCRBV12-02*01	TCRBD02-01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGTTACGATTGGACTTCCAATGAGCAGTTCTTCGGGCCA	CASSYDWTSNEQFF	In	VDJ	1	11	5.962059620596206E-4	7.698768197088465E-4	42	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	4	1	10	6	6	2	23	36	47	42	49						01,02							Vb 14	CASSYDWTSNEQFF+TCRBV27-01+TCRBJ02-01	TCRBV27-01*01	TCRBD02-01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCAACCAGACCTCTCTGTACTTCTGTGCCAGCAGAACTAGCGGGGGCCTTAGCACAGATACGCAGTATTTTGGCCCA	CASRTSGGLSTDTQYF	In	VDJ	2	70	0.003794037940379404	0.004899216125419933	48	TCRBV27	TCRBV27-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	3	2	0	1	4	23	34	46	35	50													Vb 14	CASRTSGGLSTDTQYF+TCRBV27-01+TCRBJ02-03	TCRBV27-01*01	TCRBD02-01*01	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAACCCAAGGGGTTCGTCACTGAAGCTTTCTTTGGACAA	CSVEPKGFVTEAFF	In	VDJ	1	11	5.962059620596206E-4	7.698768197088465E-4	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	5	2	4	4	5	25	37	46	41	51													Vb 4	CSVEPKGFVTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCTGAAGACAGCAGCATATATCTCTGCACCTGGTTGGGGGCCTACAATGAGCAGTTCTTCGGGCCA	CTWLGAYNEQFF	In	VDJ	1	13	7.046070460704607E-4	9.098544232922733E-4	36	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-01	01	10	6	1	2	7	0	25	29	-1	36	41				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CTWLGAYNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01		TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTAGGGACAGACTATAATTCACCCCTCCACTTTGGGAAC	CSVGTDYNSPLHF	In	VDJ	1	14	7.588075880758808E-4	9.798432250839866E-4	39	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	6	0	5	3	1	1	25	33	41	34	42													Vb 4	CSVGTDYNSPLHF+TCRBV29-01+TCRBJ01-06	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACCTCGGGGGGGCGGACTATGGCTACACCTTCGGTTCG	CSVDLGGADYGYTF	In	VDJ	1	15	8.130081300813008E-4	0.0010498320268757	42	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	3	8	0	3	3	3	25	36	47	39	50													Vb 4	CSVDLGGADYGYTF+TCRBV29-01+TCRBJ01-02	TCRBV29-01*01	TCRBD02-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGACTCGGGGGCCGACAACACCGGGGAGCTGTTTTTTGGAGAA	CSVDSGADNTGELFF	In	VDJ	1	16	8.672086720867209E-4	0.0011198208286674132	45	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-02	01	3	6	0	2	3	4	25	36	45	39	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVDSGADNTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01		TCRBJ02-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTCTCACGTTACAGATGAACACTGAAGCTTTCTTTGGACAA	CSVLTLQMNTEAFF	In	VDJ	1	17	9.214092140921409E-4	0.0011898096304591265	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	5	0	8	1	25	34	46	42	47													Vb 4	CSVLTLQMNTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAGGAGGGTCGGGTGACTGAAGCTTTCTTTGGACAA	CSVEEGRVTEAFF	In	VDJ	1	23	0.0012466124661246612	0.0016097424412094064	39	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	3	10	0	5	0	7	25	-1	42	36	49													Vb 4	CSVEEGRVTEAFF+TCRBV29-01+TCRBJ01-01	TCRBV29-01*01	TCRBD02-01*02	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGGCTTACAGGGGAACTCCTACGAGCAGTACTTCGGGCCG	CSVGLQGNSYEQYF	In	VDJ	1	26	0.0014092140921409214	0.0018197088465845466	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	2	0	4	2	25	35	46	39	48													Vb 4	CSVGLQGNSYEQYF+TCRBV29-01+TCRBJ02-07	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGAAGGGGACGGCAATCAGCCCCAGCATTTTGGTGAT	CSVEGDGNQPQHF	In	VDJ	1	33	0.0017886178861788618	0.0023096304591265398	39	TCRBV29	TCRBV29-01	01				TCRBJ01	TCRBJ01-05	01	1	0	7	2	0	1	25	-1	43	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVEGDGNQPQHF+TCRBV29-01+TCRBJ01-05	TCRBV29-01*01		TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTGCCTGGACGCGCACAGATACGCAGTATTTTGGCCCA	CSVAWTRTDTQYF	In	VDJ	1	38	0.002059620596205962	0.0026595744680851063	39	TCRBV29	TCRBV29-01	01				TCRBJ02	TCRBJ02-03	01	4	1	7	1	3	2	25	35	42	38	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 4	CSVAWTRTDTQYF+TCRBV29-01+TCRBJ02-03	TCRBV29-01*01		TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTTATTAAAATGGACTCAAGGATGGGACTGAACAATGAGCAGTTCTTCGGGCCA	CSVIKMDSRMGLNNEQFF	In	VDJ	1	42	0.0022764227642276423	0.0029395296752519596	54	TCRBV29	TCRBV29-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	0	10	5	20	2	25	34	60	54	62						01,02							Vb 4	CSVIKMDSRMGLNNEQFF+TCRBV29-01+TCRBJ02-01	TCRBV29-01*01	TCRBD02-01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCTGAAGACAGCAGCATATATCTCTGCAGCGTGGGGACAGGGCTGAACACCGGGGAGCTGTTTTTTGGAGAA	CSVGTGLNTGELFF	In	VDJ	1	49	0.0026558265582655827	0.0034294512877939528	42	TCRBV29	TCRBV29-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	0	3	1	1	2	25	33	43	34	45													Vb 4	CSVGTGLNTGELFF+TCRBV29-01+TCRBJ02-02	TCRBV29-01*01	TCRBD01-01*01	TCRBJ02-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGGGGACTTGGCTGTGTATCTCTGTGCCAGCAGCCCCCCGGGGGTTGGTAGAACAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	35	0.001897018970189702		46	TCRBV07	TCRBV07-01	01	TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	5	8	2	7	4	9	22	34	44	38	53														X+TCRBV07-01+TCRBJ01-05	TCRBV07-01*01	TCRBD02-01*01	TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCTGGTGAGACCCAGTACTTCGGGCCA	CASSESGETQYF	In	VDJ	1	12	6.504065040650406E-4	8.398656215005599E-4	36	TCRBV10	TCRBV10-02	01				TCRBJ02	TCRBJ02-05	01	0	0	10	5	1	1	23	40	43	41	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSESGETQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01		TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGAGGGACAGGGGCCTATGGCTACACCTTCGGTTCG	CASRGTGAYGYTF	In	VDJ	1	13	7.046070460704607E-4	9.098544232922733E-4	39	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	2	4	1	1	23	34	45	35	46													Vb 12	CASRGTGAYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTACCCCGGGACAGGGGACATATGGCTACACCTTCGGTTCG	CASSTPGQGTYGYTF	In	VDJ	1	13	7.046070460704607E-4	9.098544232922733E-4	45	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	2	5	5	3	23	35	50	40	53													Vb 12	CASSTPGQGTYGYTF+TCRBV10-02+TCRBJ01-02	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCCCAGACATCTGTGTATTTCTGCGCCAGCAGTACCCCCAACGGACTAGCGGGGGGCGGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSTPNGLAGGGSYNEQFF	In	VDJ	1	15	8.130081300813008E-4	0.0010498320268757	60	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	1	1	0	9	3	21	33	56	42	59													Vb 12	CASSTPNGLAGGGSYNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD02-01*01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGCTCCTTGCTTGGAGCGGTAGAGACCCAGTACTTCGGGCCA	CASSSLLGAVETQYF	In	VDJ	1	17	9.214092140921409E-4	0.0011898096304591265	45	TCRBV10	TCRBV10-02	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	6	5	4	12	1	23	34	51	46	52						01,02							Vb 12	CASSSLLGAVETQYF+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD02-01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGATCGCAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSDRSSYNEQFF	In	VDJ	1	21	0.0011382113821138211	0.0014697648376259798	42	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	3	4	5	0	3	0	23	37	-1	40	43													Vb 12	CASSDRSSYNEQFF+TCRBV10-02+TCRBJ02-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAAAAACCCCAGGGAAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	29	0.0015718157181571816		41	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	4	3	2	7	1	23	33	45	40	46													Vb 12	X+TCRBV10-02+TCRBJ01-01	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGAGTCAGTACAGGGTCCTTTGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	53	0.002872628726287263		47	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	3	3	5	3	6	23	40	49	43	55													Vb 12	X+TCRBV10-02+TCRBJ02-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GCTCCCAGACATCTGTGTATTTCTGCGCCAGCAGTGCACACCATAAGGGGTGAAATCAGCCCCAGCATTTTGGTGAT	CASSAHHKG*NQPQHF	Stop	VDJ	2	58	0.003143631436314363		48	TCRBV10	TCRBV10-02	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	5	2	4	9	3	23	36	50	45	53													Vb 12	CASSAHHKG*NQPQHF+TCRBV10-02+TCRBJ01-05	TCRBV10-02*01	TCRBD01-01*01	TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCTCTTCGGCCTCCGTGGGCAATCAGCCCCAGCATTTTGGTGAT	CASSSASVGNQPQHF	In	VDJ	1	15	8.130081300813008E-4	0.0010498320268757	45	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-05	01	10	9	0	2	7	8	24	31	41	38	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CASSSASVGNQPQHF+TCRBV10-03+TCRBJ01-05	TCRBV10-03*01		TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCTCGAATTGGTGGGGGCAGGACTATGGCTACACCTTCGGTTCG	CASSNWWGQDYGYTF	In	VDJ	1	17	9.214092140921409E-4	0.0011898096304591265	45	TCRBV10	TCRBV10-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	10	6	0	3	12	3	24	31	49	43	52													Vb 12	CASSNWWGQDYGYTF+TCRBV10-03+TCRBJ01-02	TCRBV10-03*01	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCATCAGTGAAGGACGAGATGGGAGCAATCAGCCCCAGCATTTTGGTGAT	CAISEGRDGSNQPQHF	In	VDJ	1	32	0.0017344173441734417	0.0022396416573348264	48	TCRBV10	TCRBV10-03	01				TCRBJ01	TCRBJ01-05	01	3	1	7	1	1	8	24	38	43	39	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 12	CAISEGRDGSNQPQHF+TCRBV10-03+TCRBJ01-05	TCRBV10-03*01		TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGGCTAGCGGGAGAGACCCAGTACTTCGGGCCA	CASRLAGETQYF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	4	4	4	1	0	27	38	-1	39	47			01,02			01,02							Vb 17	CASRLAGETQYF+TCRBV19-01+TCRBJ02-05	TCRBV19-01	TCRBD02-01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGCCCCAGAAATTATTCACCTCTCCACTTTGGGAAC		Out	VDJ	1	10	5.420054200542005E-4		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	3	4	5	16	5	13	27	41	49	46	62			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-06	TCRBV19-01	TCRBD01-01*01	TCRBJ01-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTTGGGGTAATTCACCCCTCCACTTTGGGAAC	CASSIWGNSPLHF	In	VDJ	1	17	9.214092140921409E-4	0.0011898096304591265	39	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-06	01	3	6	2	6	2	0	27	41	-1	43	47			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIWGNSPLHF+TCRBV19-01+TCRBJ01-06	TCRBV19-01		TCRBJ01-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGGGGGACAAGTTGAAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	24	0.0013008130081300813		47	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	0	6	0	2	8	27	39	47	41	55			01,02										Vb 17	X+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATTGACAGGGGGCCCACTGAAGCTTTCTTTGGACAA	CASSIDRGPTEAFF	In	VDJ	1	26	0.0014092140921409214	0.0018197088465845466	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	0	4	1	1	27	41	52	42	53			01,02										Vb 17	CASSIDRGPTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGGGGGCCTTGAAGCTTTCTTTGGACAA	CASSIGGLEAFF	In	VDJ	1	27	0.0014634146341463415	0.0018896976483762599	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	7	0	7	0	2	27	-1	48	43	50			01,02										Vb 17	CASSIGGLEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCATGGAAACGCAGTATTTTGGCCCA	CASSIMETQYF	In	VDJ	1	29	0.0015718157181571816	0.0020296752519596865	33	TCRBV19	TCRBV19-01					TCRBJ02	TCRBJ02-03	01	3	1	8	9	3	1	27	41	47	44	48			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIMETQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01		TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACGAATAGGGGCCTAGCGGGGGCCACAGATACGCAGTATTTTGGCCCA	CASTNRGLAGATDTQYF	In	VDJ	1	31	0.0016802168021680217	0.002169652855543113	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	7	4	2	2	11	1	27	37	58	48	59			01,02										Vb 17	CASTNRGLAGATDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAAAGTCAGGGGTGAACGGGTCACTGAAGCTTTCTTTGGACAA	CAKVRGERVTEAFF	In	VDJ	1	33	0.0017886178861788618	0.0023096304591265398	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	10	4	2	4	4	9	27	34	44	38	53			01,02										Vb 17	CAKVRGERVTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATGAGGGACAGGGGATTGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	33	0.0017886178861788618		44	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	0	2	7	2	2	27	41	53	43	55			01,02										Vb 17	X+TCRBV19-01+TCRBJ01-04	TCRBV19-01	TCRBD01-01*01	TCRBJ01-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTAATGCGGGACAGGGGTTCTATGGCTACACCTTCGGTTCG	CASSNAGQGFYGYTF	In	VDJ	1	35	0.001897018970189702	0.0024496080627099664	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	0	2	4	4	2	27	40	54	44	56			01,02										Vb 17	CASSNAGQGFYGYTF+TCRBV19-01+TCRBJ01-02	TCRBV19-01	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTGGGACAGGGGCCTACGAGCAGTACTTCGGGCCG	CASGTGAYEQYF	In	VDJ	1	37	0.002005420054200542	0.002589585666293393	36	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	8	0	2	2	0	0	27	-1	-1	36	46			01,02										Vb 17	CASGTGAYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD01-01*01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCTCCCGCGGGGGTACCTACGAGCAGTACTTCGGGCCG	CASRGGTYEQYF	In	VDJ	1	40	0.002168021680216802	0.002799552071668533	36	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	11	7	2	2	4	2	27	33	44	37	46			01,02										Vb 17	CASRGGTYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATAGATCACCGTCTCACTGAAGCTTTCTTTGGACAA	CASSIDHRLTEAFF	In	VDJ	1	43	0.0023306233062330623	0.003009518477043673	42	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	0	3	7	4	2	5	27	44	48	46	53			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSIDHRLTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCCTTAAGAGCGGGGGCACAGATACGCAGTATTTTGGCCCA	CASSILKSGGTDTQYF	In	VDJ	1	46	0.0024932249322493225	0.003219484882418813	48	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	3	6	3	1	7	0	27	41	-1	48	55			01,02										Vb 17	CASSILKSGGTDTQYF+TCRBV19-01+TCRBJ02-03	TCRBV19-01	TCRBD02-01*01	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTTCCTTACAGGGCCCCCTCTCTGGGGCTAACGTCCTGACTTTCGGGGCC	CASSSLQGPLSGANVLTF	In	VDJ	1	52	0.002818428184281843	0.003639417693169093	54	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	3	3	10	5	16	27	39	50	44	66			01,02										Vb 17	CASSSLQGPLSGANVLTF+TCRBV19-01+TCRBJ02-06	TCRBV19-01	TCRBD01-01*01	TCRBJ02-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGCCTTAACCAGGGACTGAACACTGAAGCTTTCTTTGGACAA	CASSLNQGLNTEAFF	In	VDJ	2	57	0.003089430894308943	0.003989361702127659	45	TCRBV19	TCRBV19-01					TCRBJ01	TCRBJ01-01	01	6	0	7	0	9	0	27	38	-1	47	52			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 17	CASSLNQGLNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01		TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTGCAACTAGCGGCCGTAACTCCTACAATGAGCAGTTCTTCGGGCCA	CASSATSGRNSYNEQFF	In	VDJ	2	67	0.0036314363143631436	0.004689249720044793	51	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	3	5	0	3	6	27	39	50	42	56			01,02			01,02							Vb 17	CASSATSGRNSYNEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTACCCTCCGGACAGGGGGGCGGCAGCCCCAGCATTTTGGTGAT	CASTLRTGGRQPQHF	In	VDJ	2	70	0.003794037940379404	0.004899216125419933	45	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	1	1	7	6	4	27	37	53	43	57			01,02										Vb 17	CASTLRTGGRQPQHF+TCRBV19-01+TCRBJ01-05	TCRBV19-01	TCRBD01-01*01	TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTATCGGAGGGGCTAAGTACGAGCAGTACTTCGGGCCG	CASSIGGAKYEQYF	In	VDJ	2	73	0.003956639566395664	0.005109182530795073	42	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	3	10	0	4	1	6	27	41	48	42	54			01,02										Vb 17	CASSIGGAKYEQYF+TCRBV19-01+TCRBJ02-07	TCRBV19-01	TCRBD02-01*02	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAACAAACACCGAATGAACACTGAAGCTTTCTTTGGACAA	CASNKHRMNTEAFF	In	VDJ	3	91	0.004932249322493225	0.006368980963045913	42	TCRBV19	TCRBV19-01		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	6	0	0	9	27	-1	40	37	49			01,02										Vb 17	CASNKHRMNTEAFF+TCRBV19-01+TCRBJ01-01	TCRBV19-01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAAAAGAACCCGACAGCTTTCTATCTCTGTGCCAGTAGTCCCGAGGGGAGGGGCGAGCAGTTCTTCGGGCCA	CASSPEGRGEQFF	In	VDJ	3	120	0.0065040650406504065	0.0083986562150056	39	TCRBV19	TCRBV19-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	9	0	10	6	2	27	39	52	45	54			01,02										Vb 17	CASSPEGRGEQFF+TCRBV19-01+TCRBJ02-01	TCRBV19-01	TCRBD02-01*02	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAATGGAGGGGACAGCCTAATGAAAAACTGTTTTTTGGCAGT	CASSEWRGQPNEKLFF	In	VDJ	1	13	7.046070460704607E-4	9.098544232922733E-4	48	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	0	5	3	4	1	23	39	50	43	51													Vb 11	CASSEWRGQPNEKLFF+TCRBV25-01+TCRBJ01-04	TCRBV25-01*01	TCRBD01-01*01	TCRBJ01-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAACCGACCCGGGGACAGGGCCCAAAACATTCAGTACTTCGGCGCC	CANRPGDRAQNIQYF	In	VDJ	1	26	0.0014092140921409214	0.0018197088465845466	45	TCRBV25	TCRBV25-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	10	0	3	5	9	3	23	30	48	39	51													Vb 11	CANRPGDRAQNIQYF+TCRBV25-01+TCRBJ02-04	TCRBV25-01*01	TCRBD01-01*01	TCRBJ02-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCACATACCTCTCAGTACCTCTGTGCCAGCAGTGAAGGGCTCACGGGGACCTACACAGATACGCAGTATTTTGGCCCA	CASSEGLTGTYTDTQYF	In	VDJ	1	37	0.002005420054200542	0.002589585666293393	51	TCRBV25	TCRBV25-01	01				TCRBJ02	TCRBJ02-03	01	2	0	7	2	9	3	23	38	52	47	55				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 11	CASSEGLTGTYTDTQYF+TCRBV25-01+TCRBJ02-03	TCRBV25-01*01		TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGTTATCCCGGGACCCCCGGCAATGGTGGCTACACCTTCGGTTCG	CASSYPGTPGNGGYTF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	48	TCRBV07	unresolved					TCRBJ01	TCRBJ01-02	01	6	0	7	7	7	12	19	30	42	37	54		TCRBV07-05,TCRBV07-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYPGTPGNGGYTF+TCRBV07-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AGGACTCGGCCCTSTATCTCTGTGCCAGCAGCTTCCACGGGCACCAAGAGACCCAGTACTTCGGGCCA	CASSFHGHQETQYF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	42	TCRBV05	unresolved					TCRBJ02	TCRBJ02-05	01	2	8	0	0	4	0	19	33	-1	37	41		TCRBV05-06,TCRBV05-07,TCRBV05-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFHGHQETQYF+TCRBV05-X+TCRBJ02-05	unresolved		TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CTCCCTCYCAGACWTCTGTWTACTTCTGTGCCAGCGATCGCACATCCGGGACAGGGGTATGGCTACACCTTCGGTTCG		Out	VDJ	1	12	6.504065040650406E-4		46	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	8	0	2	5	12	0	26	35	-1	47	57		TCRBV06-07,TCRBV06-09												X+TCRBV06-X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCTTGGCCGGGGGGGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSLAGGATGELFF	In	VDJ	1	12	6.504065040650406E-4	8.398656215005599E-4	45	TCRBV11	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	3	8	0	4	3	1	18	32	43	35	44		TCRBV11-01,TCRBV11-03												CASSLAGGATGELFF+TCRBV11-X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCACCAGAGGACGGAACTCTGGAAACACCATATATTTTGGAGAG	CATRGRNSGNTIYF	In	VDJ	1	13	7.046070460704607E-4	9.098544232922733E-4	42	TCRBV06	unresolved					TCRBJ01	TCRBJ01-03	01	6	1	7	0	1	4	26	37	42	38	46		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATRGRNSGNTIYF+TCRBV06-X+TCRBJ01-03	unresolved		TCRBJ01-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTSCTCCCAGACATCTGTRTATTTCTGCGCCAGCAGTCGGAGGGAGGCCTACAATGAGCAGTTCTTCGGGCCA	CASSRREAYNEQFF	In	VDJ	1	13	7.046070460704607E-4	9.098544232922733E-4	42	TCRBV10	unresolved		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	5	9	1	2	4	0	23	35	-1	39	45		TCRBV10-01,TCRBV10-02												CASSRREAYNEQFF+TCRBV10-X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TGYWCCCTCTCAGACWTCTGTKTACTTCTGTGCCAGCACCGTTACAGGGAATACTGAAGCTTTCTTTGGACAA	CASTVTGNTEAFF	In	VDJ	1	21	0.0011382113821138211	0.0014697648376259798	39	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	3	3	5	5	3	28	38	49	43	52		TCRBV06-04,TCRBV06-07												CASTVTGNTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCGGCCCTSTATCTCTGTGCCAGCAGCTTCTACGGGGGGAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSFYGGSSYNEQFF	In	VDJ	1	27	0.0014634146341463415	0.0018896976483762599	48	TCRBV05	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	8	1	0	3	2	19	33	43	36	45		TCRBV05-05,TCRBV05-06,TCRBV05-07												CASSFYGGSSYNEQFF+TCRBV05-X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CTCCCTCCCAGACATCTGTRTACTTSTGTGCCAGCAGTTATCAACCAGAAAGATACGAGCAGTACTTCGGGCCG	CASSYQPERYEQYF	In	VDJ	1	30	0.0016260162601626016	0.0020996640537514	42	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	5	4	4	5	26	41	48	45	53		TCRBV06-08,TCRBV06-09												CASSYQPERYEQYF+TCRBV06-X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
SGACTCRGCYRTGTATCKCTGTGCCAGCAGCCCGTTTGTGGCAGGGCGGTCTGTGAACACTGAAGCTTTCTTTGGACAA	CASSPFVAGRSVNTEAFF	In	VDJ	1	52	0.002818428184281843	0.003639417693169093	54	TCRBV07	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	4	3	0	10	7	19	31	46	41	53		TCRBV07-05,TCRBV07-07												CASSPFVAGRSVNTEAFF+TCRBV07-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCATCACGGGGACTAGCGGGGGACCTGGCACAGATACGCAGTATTTTGGCCCA	CAITGTSGGPGTDTQYF	In	VDJ	2	59	0.003197831978319783	0.004129339305711086	51	TCRBV06	unresolved		TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	10	0	2	1	5	5	23	30	49	35	54		TCRBV06-07,TCRBV06-08												CAITGTSGGPGTDTQYF+TCRBV06-X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGCTCCCCCGCCTATGGCTACACCTTCGGTTCG	CASSSPAYGYTF	In	VDJ	2	61	0.0033062330623306233	0.0042693169092945125	36	TCRBV06	unresolved					TCRBJ01	TCRBJ01-02	01	6	10	0	4	7	0	26	37	-1	44	46		TCRBV06-07,TCRBV06-08		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSPAYGYTF+TCRBV06-X+TCRBJ01-02	unresolved		TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGTCCTCAAGGGGCCTCGAACACTGAAGCTTTCTTTGGACAA	CASSPQGASNTEAFF	In	VDJ	2	67	0.0036314363143631436	0.004689249720044793	45	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	2	1	5	4	23	35	45	40	49		TCRBV06-07,TCRBV06-08												CASSPQGASNTEAFF+TCRBV06-X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CTCCCTCYCAGACWTCTGTKTACTTSTGTGCCAGCAGCCCCCCTGGACAGGGGATGACCTTTAGGGAAAAACTGTTTTTTGGCAGT	CASSPPGQGMTFREKLFF	In	VDJ	4	140	0.007588075880758808	0.009798432250839866	54	TCRBV06	unresolved		TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	1	2	8	7	12	26	37	53	44	65		TCRBV06-07,TCRBV06-08												CASSPPGQGMTFREKLFF+TCRBV06-X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTGAAGTGGCTGCGGGGGTACGAAATGAGCAGTTCTTCGGGCCA	CASSEVAAGVRNEQFF	In	VDJ	1	16	8.672086720867209E-4	0.0011198208286674132	48	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	1	7	2	7	5	5	23	39	51	44	56													Vb 22	CASSEVAAGVRNEQFF+TCRBV02-01+TCRBJ02-01	TCRBV02-01*01	TCRBD02-01*01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGTCGGGAGACAAATGAAAAACTGTTTTTTGGCAGT	CASSRETNEKLFF	In	VDJ	1	18	9.75609756097561E-4	0.0012597984322508398	39	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	8	2	5	0	3	23	-1	41	35	44													Vb 22	CASSRETNEKLFF+TCRBV02-01+TCRBJ01-04	TCRBV02-01*01	TCRBD02-01*02	TCRBJ01-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TGGAGGACTCAGCCATGTACTTCTGTGCCAGCAGCGTAGGAGGGGAGGGAGCGAGCAGTACTTCGGGCCG		Out	VDJ	1	24	0.0013008130081300813		41	TCRBV02	TCRBV02-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	6	9	0	6	8	2	23	34	49	42	51													Vb 22	X+TCRBV02-01+TCRBJ02-07	TCRBV02-01*01	TCRBD02-01*02	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TGTACCCTCTCAGACATCTGTGTACTTCTGTGCCAGCAGTGTCATTCTCCACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSVILHSGANVLTF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	48	TCRBV06	TCRBV06-04					TCRBJ02	TCRBJ02-06	01	4	4	6	0	1	7	28	41	44	42	51			01,02	TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSVILHSGANVLTF+TCRBV06-04+TCRBJ02-06	TCRBV06-04		TCRBJ02-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCAGTCGTTTGTTGCGTATTTACAAAGGGCCAACGTCCTGACTTTCGGGGCC		Out	VDJ	1	39	0.002113821138211382		53	TCRBV06	TCRBV06-07	01				TCRBJ02	TCRBJ02-06	01	5	3	6	5	16	2	26	38	57	54	59				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-07+TCRBJ02-06	TCRBV06-07*01		TCRBJ02-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CTCCCTCTCAGACTTCTGTTTACTTCTGTGCCAGCGGCGTCGGGGGGTTCCAGTATTTTGGCCCA	CASGVGGFQYF	In	VDJ	8	287	0.015555555555555555	0.020086786114221725	33	TCRBV06	TCRBV06-07	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	8	8	1	12	5	3	26	35	47	40	50														CASGVGGFQYF+TCRBV06-07+TCRBJ02-03	TCRBV06-07*01	TCRBD02-01*01	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTACAGACAGGGGACATACAATGAGCAGTTCTTCGGGCCA	CASSYRQGTYNEQFF	In	VDJ	1	12	6.504065040650406E-4	8.398656215005599E-4	45	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	4	2	2	4	3	3	19	32	43	35	46														CASSYRQGTYNEQFF+TCRBV07-07+TCRBJ02-01	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCGGGGGGACATCCTACAATGAGCAGTTCTTCGGGCCA	CASSGGTSYNEQFF	In	VDJ	1	17	9.214092140921409E-4	0.0011898096304591265	42	TCRBV07	TCRBV07-07	01				TCRBJ02	TCRBJ02-01	01	5	0	6	1	3	0	19	31	-1	34	40				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGGTSYNEQFF+TCRBV07-07+TCRBJ02-01	TCRBV07-07*01		TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCCAATCGTCCTTATTCAGGGGGCAGGGGGCCAACGTCCTGACTTTCGGGGCC	CASSQSSLFRGQGANVLTF	In	VDJ	1	29	0.0015718157181571816	0.0020296752519596865	57	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	5	4	0	4	14	2	19	31	53	45	55														CASSQSSLFRGQGANVLTF+TCRBV07-07+TCRBJ02-06	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCAGCCATGTATCGCTGTGCCAGCAGCTCCGGACAGGCCCTCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSGQALSGANVLTF	In	VDJ	1	46	0.0024932249322493225	0.003219484882418813	51	TCRBV07	TCRBV07-07	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	1	4	0	2	4	19	32	41	34	45														CASSSGQALSGANVLTF+TCRBV07-07+TCRBJ02-06	TCRBV07-07*01	TCRBD01-01*01	TCRBJ02-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CACCAGCCAAACAGCTTTGTACTTCTGTCCTGGGAGCGCACTGTTCCGGGGCCCGCACCACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	73	0.003956639566395664		49	TCRBV22	TCRBV22-01	01				TCRBJ01	TCRBJ01-01	01	0	7	0	4	6	6	25	41	52	47	58				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV22-01+TCRBJ01-01	TCRBV22-01*01		TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACCCAGGGACTCAGCTGTGTAYTTYTGTACCAGCAGTGAAGACCTCAGGGTTTTTGGCTACACCTTCGGTTCG	CTSSEDLRVFGYTF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	42	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	3	7	8	4	26	38	51	46	55		TCRBV12-03,TCRBV12-04,TCRBV12-05												CTSSEDLRVFGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTATTCGGGACTAGCGTGGCCGGGGRGCTGTTTTTTGGAGAA	CASSLFGTSVAGXLFF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	48	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	2	0	6	13	3	10	26	41	54	44	64		TCRBV12-03,TCRBV12-04				01,02								CASSLFGTSVAGXLFF+TCRBV12-X+TCRBJ02-02	TCRBV12	TCRBD02-01	TCRBJ02-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGCACGGTTAACACTGAAGCTTTCTTTGGACAA	CASSLGTVNTEAFF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	8	5	2	3	2	26	42	48	45	50		TCRBV12-03,TCRBV12-04				01,02								CASSLGTVNTEAFF+TCRBV12-X+TCRBJ01-01	TCRBV12	TCRBD02-01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACCGGGACTAGCGGGGTCTACAATGAGCAGTTCTTCGGGCCA	CSATGTSGVYNEQFF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	0	3	3	2	1	26	36	51	38	52		TCRBV20-01,TCRBV20-or09_02												CSATGTSGVYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01*01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GCWSSSASWCAKCTGTGTAYTTCTGYGCTAGCAGTTACTCGTTACTAGCGGGCGCCGGGAACACCGGGGAGCTGTTTTTTGGAGAA	CASSYSLLAGAGNTGELFF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	57	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	3	4	1	7	6	22	35	51	42	57	TCRBV10,TCRBV12					01,02								CASSYSLLAGAGNTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAGAAGACTCRGCCSTGTATSTCTGYGCCAGCAGCCGAAGGACAGGGGAGAGCTATGGCTACACCTTCGGTTCG	CASSRRTGESYGYTF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	1	2	4	4	4	18	30	43	34	47	TCRBV04,TCRBV11													CASSRRTGESYGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACCCAGGGACTCRGCYGTGTATKTYTGTGCCAGCAGCTTAGCGCGCCGACAGGGCTACGAGCAGTACTTCGGGCCG	CASSLARRQGYEQYF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	2	3	3	5	0	18	35	-1	40	47	TCRBV07,TCRBV11,TCRBV12													CASSLARRQGYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCTTAGGTCTCACGAACACTGAAGCTTTCTTTGGACAA	CASSLGLTNTEAFF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	42	unresolved						TCRBJ01	TCRBJ01-01	01	1	3	7	1	5	0	18	34	-1	39	41	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGLTNTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GRGACWCRGCMMTGTATCKCTGYGCCAGCAGCCAAGTAGGGGTTAGCTACGAGCAGTACTTCGGGCCG	CASSQVGVSYEQYF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	5	2	3	5	4	19	31	41	36	45	TCRBV07,TCRBV23													CASSQVGVSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCRGCCRTGTATSKCTGTGCCAGCAGCCCTAATCCTACAGGTCTGAACACTGAAGCTTTCTTTGGACAA	CASSPNPTGLNTEAFF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	4	0	9	2	19	31	45	40	47	TCRBV07,TCRBV11													CASSPNPTGLNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TGGAGGACTCAGCCATGTAYYKCTGTGCCAGCAGCTTGTTTAGCGGGGGCAACCAAGAGACCCAGTACTTCGGGCCA	CASSLFSGGNQETQYF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	3	5	2	0	3	2	19	33	45	36	47	TCRBV02,TCRBV07													CASSLFSGGNQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
SGACTCRGCYGTGTATCTCTGTGCCAGCAGCTTAGAGATCCAGGGAAGGATAAGTGGCTACACCTTCGGTTCG	CASSLEIQGRISGYTF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	3	7	6	9	19	34	45	40	54	TCRBV07,TCRBV11													CASSLEIQGRISGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCGGCCATGTATCKCTGTGCCAGCAGCCCCGAGATAACTAATGAAAAACTGTTTTTTGGCAGT	CASSPEITNEKLFF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	5	11	2	1	3	2	19	31	37	34	39	TCRBV07,TCRBV11													CASSPEITNEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGTGATAAGGGCAACCACTATGGCTACACCTTCGGTTCG	CASSDKGNHYGYTF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	42	TCRBV05						TCRBJ01	TCRBJ01-02	01	5	5	3	3	5	5	19	30	39	35	44		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSDKGNHYGYTF+TCRBV05-X+TCRBJ01-02	TCRBV05		TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ARGRRGACTCAGCTGYGTATCTCTGYGCCAGCAGCCCCCGGGACAGCTTATTCTCTGGAAACACCATATATTTTGGAGAG	CASSPRDSLFSGNTIYF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	5	0	5	0	4	6	22	34	45	38	51	TCRBV01,TCRBV07													CASSPRDSLFSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD01-01*01	TCRBJ01-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGGGGACTYGGCYRTGTATCTCTGTGCCAGCAGCCCAGACGGAGTTATTAGAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	10	5.420054200542005E-4		47	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-06	01	1	10	2	7	2	7	22	38	44	40	51	TCRBV07,TCRBV11													X+X+TCRBJ01-06	unresolved	TCRBD02-01*02	TCRBJ01-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TGTACSCTCYCAGACATCTGTGTAYTTCTGYGCCATCATCATGACTAGCGGGGGTTCAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	10	5.420054200542005E-4		44	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	10	2	2	6	7	2	28	35	54	42	56	TCRBV06,TCRBV10													X+X+TCRBJ02-01	unresolved	TCRBD02-01*01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAACTCCCTAGGACAGGGCCCATATGGCTACACCTTCGGTTCG	CASNSLGQGPYGYTF	In	VDJ	1	11	5.962059620596206E-4	7.698768197088465E-4	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	1	3	5	8	4	26	36	52	44	56		TCRBV03-01,TCRBV03-02												CASNSLGQGPYGYTF+TCRBV03-X+TCRBJ01-02	TCRBV03	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACTGGGGTTGCAGGGCCCTGGAAACACCATATATTTTGGAGAG	CSARLGLQGPGNTIYF	In	VDJ	1	11	5.962059620596206E-4	7.698768197088465E-4	48	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	2	4	3	2	9	2	26	38	52	47	54		TCRBV20-01,TCRBV20-or09_02												CSARLGLQGPGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGAAACTGGAGAGACCCAGTACTTCGGGCCA	CSASETGETQYF	In	VDJ	1	11	5.962059620596206E-4	7.698768197088465E-4	36	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	3	3	10	4	4	2	26	37	44	41	46		TCRBV20-01,TCRBV20-or09_02				01,02								CSASETGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTGACTCGGGACAGAGTTTCTATAGCAATCAGCCCCAGCATTTTGGTGAT	CSASDSGQSFYSNQPQHF	In	VDJ	1	11	5.962059620596206E-4	7.698768197088465E-4	54	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	3	0	5	0	6	8	26	37	50	43	58		TCRBV20-01,TCRBV20-or09_02												CSASDSGQSFYSNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTCCCCCTCGGGACGGATATAATTCACCCCTCCACTTTGGGAAC	CASSPPRDGYNSPLHF	In	VDJ	1	11	5.962059620596206E-4	7.698768197088465E-4	48	TCRBV24						TCRBJ01	TCRBJ01-06	01	6	0	7	4	7	3	24	36	48	43	51		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPPRDGYNSPLHF+TCRBV24-X+TCRBJ01-06	TCRBV24		TCRBJ01-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCCGGCGGACAGGGGAGGACAGATACGCAGTATTTTGGCCCA	CASSPGGQGRTDTQYF	In	VDJ	1	12	6.504065040650406E-4	8.398656215005599E-4	48	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	2	3	7	3	26	37	53	44	56		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSPGGQGRTDTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCTTACAGGGGAAGAGTACGCAGTATTTTGGCCCA	CASSLQGKSTQYF	In	VDJ	1	12	6.504065040650406E-4	8.398656215005599E-4	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	2	4	2	8	0	5	26	-1	47	41	52		TCRBV12-03,TCRBV12-04												CASSLQGKSTQYF+TCRBV12-X+TCRBJ02-03	TCRBV12	TCRBD01-01*01	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGCTTATATCAGGGGGCGCGTAATTCACCCCTCCACTTTGGGAAC	CASSLYQGARNSPLHF	In	VDJ	1	12	6.504065040650406E-4	8.398656215005599E-4	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	4	0	6	3	3	26	41	52	44	55	TCRBV12,TCRBV21													CASSLYQGARNSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGCCGGGCTGGGGGGGTCAGCCCCAGCATTTTGGTGAT	CASRPGWGGQPQHF	In	VDJ	1	12	6.504065040650406E-4	8.398656215005599E-4	42	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	6	9	0	6	8	0	26	37	-1	45	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRPGWGGQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD02-01*01	TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGCGTCGGGACTAGCAACAATGAGCAGTTCTTCGGGCCA	CASSVGTSNNEQFF	In	VDJ	1	12	6.504065040650406E-4	8.398656215005599E-4	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	6	0	7	5	4	1	22	33	46	37	47		TCRBV12-03,TCRBV12-04				01,02								CASSVGTSNNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGGCGGGGGGTCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	12	6.504065040650406E-4		35	TCRBV24			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-05	01	7	7	1	6	0	0	24	-1	-1	35	43		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD02-01*01	TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCGGCCRTGTATSTCTGTGCCAGCAGCACTCAATCCCGGGGACAGGGGGCGGATATCACCGGGGAGCTGTTTTTTGGAGAA	CASSTQSRGQGADITGELFF	In	VDJ	1	12	6.504065040650406E-4	8.398656215005599E-4	60	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	5	0	0	4	11	6	18	30	53	41	59	TCRBV07,TCRBV11													CASSTQSRGQGADITGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCCGAGGGGGGGGACTGCGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	12	6.504065040650406E-4		43	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	5	9	0	6	3	7	18	30	40	33	47	TCRBV07,TCRBV11													X+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
RRGACWCGGCMCTGTATCTCTGYGCCAGCAGCTTAGCTCCCGTAGTTTACGCTAACTATGGCTACACCTTCGGTTCG	CASSLAPVVYANYGYTF	In	VDJ	1	12	6.504065040650406E-4	8.398656215005599E-4	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	6	5	7	0	2	14	20	31	37	33	51	TCRBV05,TCRBV23					01,02								CASSLAPVVYANYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ARRRRGACTCAGCYGYGTATCTCTRCACCAGCAGCAATGGTCGTAGTCGGGCCAACGTCCTGACTTTCGGGGCC	XTSSNGRSRANVLTF	In	VDJ	1	12	6.504065040650406E-4	8.398656215005599E-4	45	unresolved			unresolved			TCRBJ02	TCRBJ02-06	01	10	4	5	5	1	17	22	26	30	27	47	TCRBV01,TCRBV17			TCRBD01,TCRBD02										XTSSNGRSRANVLTF+X+TCRBJ02-06	unresolved	unresolved	TCRBJ02-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCCCTAAGGACCCCGCGAGTCCCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	12	6.504065040650406E-4		46	unresolved						TCRBJ01	TCRBJ01-01	01	4	1	7	6	5	11	19	31	40	36	51	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCGCCACAGGGGACTCCTACGAGCAGTACTTCGGGCCG	CASSATGDSYEQYF	In	VDJ	1	12	6.504065040650406E-4	8.398656215005599E-4	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	3	2	0	3	1	19	31	41	34	42	TCRBV05,TCRBV07													CASSATGDSYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCGTGCCGGGACAGGGGAAGGGGCACCAAGAGACCCAGTACTTCGGGCCA	CASSVPGQGKGHQETQYF	In	VDJ	1	12	6.504065040650406E-4	8.398656215005599E-4	54	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	2	0	5	7	19	31	46	36	53	TCRBV05,TCRBV11													CASSVPGQGKGHQETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GRGACWCGGCMCTGTATCTCTGYGCCAGCAGCTTTTCAGACACGTGGGGGACCCAGTACTTCGGGCCA	CASSFSDTWGTQYF	In	VDJ	1	12	6.504065040650406E-4	8.398656215005599E-4	42	unresolved						TCRBJ02	TCRBJ02-05	01	2	2	6	7	4	7	19	33	41	37	48	TCRBV05,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFSDTWGTQYF+X+TCRBJ02-05	unresolved		TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCTCGGGACAGAGGAATTCACCCCTCCACTTTGGGAAC	CASSSSGQRNSPLHF	In	VDJ	1	13	7.046070460704607E-4	9.098544232922733E-4	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	0	5	7	4	3	26	39	50	43	53		TCRBV12-03,TCRBV12-04												CASSSSGQRNSPLHF+TCRBV12-X+TCRBJ01-06	TCRBV12	TCRBD01-01*01	TCRBJ01-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ARCYYRGKGACTCWGCTGTGTATTTYTGTGCCAGCAGCCTAGGGTCTTATCCCCAGCATTTTGGTGAT	CASSLGSYPQHF	In	VDJ	1	13	7.046070460704607E-4	9.098544232922733E-4	36	unresolved						TCRBJ01	TCRBJ01-05	01	4	5	3	10	1	6	26	39	44	40	50	TCRBV03,TCRBV12			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLGSYPQHF+X+TCRBJ01-05	unresolved		TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGGGGAATACAGGGGCGACTGAAGCTTTCTTTGGACAA	CSARGNTGATEAFF	In	VDJ	1	13	7.046070460704607E-4	9.098544232922733E-4	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	3	2	5	7	2	26	37	51	44	53		TCRBV20-01,TCRBV20-or09_02												CSARGNTGATEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGGCTCAACCGGGACAGGGTGGCGGCTACACCTTCGGTTCG		Out	VDJ	1	13	7.046070460704607E-4		43	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	0	3	8	9	4	26	35	53	44	57		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
WMCCAGACMTCTSTGTACTTSTGTGCCAGCAGTTAGGGGAAAGGTGGTTATAGAATTTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASS*GKGGYRIYSNQPQHF	Stop	VDJ	1	13	7.046070460704607E-4		60	unresolved			unresolved			TCRBJ01	TCRBJ01-05	01	3	0	8	0	1	19	21	35	40	36	59	TCRBV06,TCRBV27			TCRBD01,TCRBD02										CASS*GKGGYRIYSNQPQHF+X+TCRBJ01-05	unresolved	unresolved	TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AAYCMRGRGACWCAGCWSKGTATTTYTGTGCCAGCAGTGAAGACCAGGGACCCTTGTATGGCTACACCTTCGGTTCG	CASSEDQGPLYGYTF	In	VDJ	1	14	7.588075880758808E-4	9.798432250839866E-4	45	unresolved						TCRBJ01	TCRBJ01-02	01	5	0	7	5	8	5	26	38	51	46	56	TCRBV12,TCRBV21			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSEDQGPLYGYTF+X+TCRBJ01-02	unresolved		TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCAGCAGCTCCCAATGGGGGGGGACTGAAGCTTTCTTTGGACAA	CASSSQWGGTEAFF	In	VDJ	1	14	7.588075880758808E-4	9.798432250839866E-4	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	6	9	0	5	8	1	24	35	50	43	51	TCRBV06,TCRBV10													CASSSQWGGTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTACCCTGGTACAGGGTGTAGGGGGCTACACCTTCGGTTCG	CASSTLVQGVGGYTF	In	VDJ	1	14	7.588075880758808E-4	9.798432250839866E-4	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	3	3	8	8	7	24	36	50	44	57	TCRBV06,TCRBV10	TCRBV06-01,TCRBV06-05,TCRBV06-06,TCRBV10-03												CASSTLVQGVGGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGGGCTCCGGGGTCACACTGAAGCTTTCTTTGGACAA	CSARDGLRGHTEAFF	In	VDJ	1	14	7.588075880758808E-4	9.798432250839866E-4	45	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	0	8	3	3	7	2	26	40	52	47	54		TCRBV20-01,TCRBV20-or09_02												CSARDGLRGHTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD02-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTCCTCGTGAGGGGCGACAGCGTACGCAGTATTTTGGCCCA	CSAPREGRQRTQYF	In	VDJ	1	14	7.588075880758808E-4	9.798432250839866E-4	42	TCRBV20						TCRBJ02	TCRBJ02-03	01	5	2	5	8	13	2	26	35	53	48	55		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAPREGRQRTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20		TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTATACAGGGGAGAGGGAAAGCTTTCTTTGGACAA	CASSIQGRGKAFF	In	VDJ	1	14	7.588075880758808E-4	9.798432250839866E-4	39	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	2	9	2	7	24	36	45	38	52		TCRBV24-01,TCRBV24-or09_02												CASSIQGRGKAFF+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAAAGGTCTGGACAGGGTCTATTCTATGGCTACACCTTCGGTTCG	CASSERSGQGLFYGYTF	In	VDJ	1	14	7.588075880758808E-4	9.798432250839866E-4	51	TCRBV06			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	1	3	4	6	6	23	38	52	44	58		TCRBV06-01,TCRBV06-08												CASSERSGQGLFYGYTF+TCRBV06-X+TCRBJ01-02	TCRBV06	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CGACTCGGCYGTGTATCTCTGTGCCAGCAGCTTAGAGGTAGCTGGGAAGGGCCACGAGCAGTACTTTGGGCCG	CASSLEVAGKGHEQYF	In	VDJ	1	14	7.588075880758808E-4	9.798432250839866E-4	48	unresolved						TCRBJ02	TCRBJ02-07	01	0	0	8	19	8	20	19	35	47	43	67	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLEVAGKGHEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTTAGCGGGACTTAACTATGGCTACACCTTCGGTTCG	CASSLAGLNYGYTF	In	VDJ	1	14	7.588075880758808E-4	9.798432250839866E-4	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	2	6	3	1	0	2	19	-1	40	33	42	TCRBV05,TCRBV11					unresolved								CASSLAGLNYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*02	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CASCWSCCARACAKCTKTGTACTTCTGTGCCAGCAGCTCCCGGGACAGGCGCCTTGAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	15	8.130081300813008E-4		49	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	4	0	5	5	24	35	48	40	53	TCRBV06,TCRBV10,TCRBV22													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGGGGGGGCGCACGGCTTACGAGCAGTACTTCGGGCCG	CSAGGRTAYEQYF	In	VDJ	1	15	8.130081300813008E-4	0.0010498320268757	39	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	9	0	4	0	9	26	-1	41	34	50		TCRBV20-01,TCRBV20-or09_02												CSAGGRTAYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD02-01*01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGGGACTAGCGAAGTGTATGCACCAGAGACCCAGTACTTCGGGCCA	CASSGTSEVYAPETQYF	In	VDJ	1	16	8.672086720867209E-4	0.0011198208286674132	51				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	1	6	4	0	13	24	-1	46	37	59	TCRBV06,TCRBV10	TCRBV06-01,TCRBV10-03				01,02								CASSGTSEVYAPETQYF+X+TCRBJ02-05		TCRBD02-01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGCAAGTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSQASATNEKLFF	In	VDJ	1	16	8.672086720867209E-4	0.0011198208286674132	45	unresolved						TCRBJ01	TCRBJ01-04	01	1	4	6	0	0	4	23	-1	41	39	45	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQASATNEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCMRGRGACWCAGCWSKGTAYTTCTGTGCCAGCAGCGGCACACAGGGTCGGTCCGCCACCGGGGAGCTGTTTTTTGGAGAA	CASSGTQGRSATGELFF	In	VDJ	1	16	8.672086720867209E-4	0.0011198208286674132	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	6	3	3	4	6	9	22	33	45	39	54	TCRBV12,TCRBV21													CASSGTQGRSATGELFF+X+TCRBJ02-02	unresolved	TCRBD01-01*01	TCRBJ02-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CTMSCTCYCAGACWTCTGTKTACTTCTGTGCCTGTTCAATTTCCGGGACGTCAAGTGAGCAGTACTTCGGGCCG	CACSISGTSSEQYF	In	VDJ	1	16	8.672086720867209E-4	0.0011198208286674132	42	unresolved						TCRBJ02	TCRBJ02-07	01	11	0	7	7	12	7	26	32	49	44	56	TCRBV06,TCRBV10			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CACSISGTSSEQYF+X+TCRBJ02-07	unresolved		TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGCCAAACGTGGGAGAACACTGAAGCTTTCTTTGGACAA	CASSQTWENTEAFF	In	VDJ	1	16	8.672086720867209E-4	0.0011198208286674132	42	unresolved						TCRBJ01	TCRBJ01-01	01	4	0	8	1	7	0	19	31	-1	38	42	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQTWENTEAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCGTGACAGGGGGTAGGACTGAAGCTTTCTTTGGACAA	CASSVTGGRTEAFF	In	VDJ	1	16	8.672086720867209E-4	0.0011198208286674132	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	2	1	5	2	4	19	31	42	33	46	TCRBV05,TCRBV11													CASSVTGGRTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCGGCCMTSTATCTCTGTGCCAGCAGCTCGGGACTCTGGGGCACTGAAGCTTTCTTTGGACAA	CASSSGLWGTEAFF	In	VDJ	1	16	8.672086720867209E-4	0.0011198208286674132	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	0	10	4	1	6	19	32	39	33	45	TCRBV05,TCRBV11					01,02								CASSSGLWGTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCGGCCMTSTATCKCTGTGCCAGCAGCTTCAGTGTGCGGGGGGAGACCCAGTACTTCGGGCCA	CASSFSVRGETQYF	In	VDJ	1	16	8.672086720867209E-4	0.0011198208286674132	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	7	2	5	6	0	19	33	-1	39	46	TCRBV05,TCRBV07													CASSFSVRGETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGGGGACTYGGCYGTGTATSTCTGTGCCAGCACCTTGCCCGAGACAGGGGGGACAGGCTACACCTTCGGTTCG	CASTLPETGGTGYTF	In	VDJ	1	16	8.672086720867209E-4	0.0011198208286674132	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	7	2	1	8	10	4	22	32	51	42	55	TCRBV07,TCRBV11													CASTLPETGGTGYTF+X+TCRBJ01-02	unresolved	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCACCCCGGCAGGTGGAGAGACCCAGTACTTCGGGCCA	CASTPAGGETQYF	In	VDJ	1	16	8.672086720867209E-4	0.0011198208286674132	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	4	4	4	6	3	23	33	43	39	46	TCRBV09,TCRBV21													CASTPAGGETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCTCTCAAGCCCCCCTCCGGGACTCCAAGAGACCCAGTACTTCGGGCCA	CASSLSSPPPGLQETQYF	In	VDJ	1	17	9.214092140921409E-4	0.0011898096304591265	54	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	6	0	10	1	18	0	26	37	-1	55	61		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSLSSPPPGLQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTCAGTATGAAGACCCAGTACTTCGGGCCA	CASSFSMKTQYF	In	VDJ	1	17	9.214092140921409E-4	0.0011898096304591265	36	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	3	4	5	6	0	5	26	-1	43	40	48		TCRBV12-03,TCRBV12-04												CASSFSMKTQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD01-01*01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCGAACAGTCGGGTTCTTTAATGAACACTGAAGCTTTCTTTGGACAA	CSAEQSGSLMNTEAFF	In	VDJ	1	17	9.214092140921409E-4	0.0011898096304591265	48	TCRBV20						TCRBJ01	TCRBJ01-01	01	6	3	5	0	3	13	26	34	41	37	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSAEQSGSLMNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20		TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AGCACCAACCAGACATCTRTGTAYCTCTRTGCCAGCAGTTTTAATTTCAGGGGGTTGAACACTGAAGCTTTCTTTGGACAA	XASSFNFRGLNTEAFF	In	VDJ	1	17	9.214092140921409E-4	0.0011898096304591265	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	1	0	6	1	25	39	52	45	53	TCRBV26,TCRBV28													XASSFNFRGLNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAGGGACTCAGCTGTGTACTTCTGTGCCAGCAGTGACTACAGGGGGATTTTAGATGAGCAGTTCTTCGGGCCA	CASSDYRGILDEQFF	In	VDJ	1	17	9.214092140921409E-4	0.0011898096304591265	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	1	8	4	7	22	34	46	38	53		TCRBV12-03,TCRBV12-04												CASSDYRGILDEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD01-01*01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGAACCGGACAGGTCCCAGGTCAGCCCCAGCATTTTGGTGAT	CASRTGQVPGQPQHF	In	VDJ	1	17	9.214092140921409E-4	0.0011898096304591265	45	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	7	1	4	6	4	7	24	35	46	39	53		TCRBV24-01,TCRBV24-or09_02												CASRTGQVPGQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24	TCRBD01-01*01	TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGACAGAGGTGCGTACAATGAGCAGTTCTTCGGGCCA	CASSQDRGAYNEQFF	In	VDJ	1	17	9.214092140921409E-4	0.0011898096304591265	45				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	0	11	1	4	2	4	18	35	41	37	45	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQDRGAYNEQFF+X+TCRBJ02-01		TCRBD02-01*02	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAATTGCAGGGGCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	18	9.75609756097561E-4		34	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	2	6	4	0	26	36	-1	40	46		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GAGACWCGGCMSTGTATSTCTGYGCCAGCAGAGCCATGGGGGGCAACCTCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	18	9.75609756097561E-4		43	unresolved						TCRBJ01	TCRBJ01-01	01	6	6	0	6	7	5	18	29	42	36	47	TCRBV11,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCGGGGCGGGACGGGCTAACTATGGCTACACCTTCGGTTCG	CASGAGRANYGYTF	In	VDJ	1	19	0.001029810298102981	0.0013297872340425532	42	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	12	6	3	0	1	9	26	31	39	32	48	TCRBV09,TCRBV12					unresolved								CASGAGRANYGYTF+X+TCRBJ01-02	unresolved	TCRBD02-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTTTATTAGGAGAGGCAAGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	19	0.001029810298102981		47	TCRBV24			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	6	10	2	3	6	8	24	36	46	42	54		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ01-01	TCRBV24	TCRBD02-01*02	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
SCTCCCAGACATCTGTGTAYTTSTGYGCCAGCAGTGACAGGGGCACAGATACGCAGTATTTTGGCCCA	CASSDRGTDTQYF	In	VDJ	1	19	0.001029810298102981	0.0013297872340425532	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	2	3	1	0	0	23	-1	-1	35	42	TCRBV06,TCRBV10													CASSDRGTDTQYF+X+TCRBJ02-03	unresolved	TCRBD01-01*01	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GAMGACTCGGCYSTGTATCTCTGTGCCAGCAGCCCCCTAGCGGGATTCAATGAGCAGTTCTTCGGGCCA	CASSPLAGFNEQFF	In	VDJ	1	19	0.001029810298102981	0.0013297872340425532	42	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-01	01	4	4	3	6	3	2	19	31	43	34	45	TCRBV04,TCRBV07													CASSPLAGFNEQFF+X+TCRBJ02-01	unresolved	TCRBD02-01*02	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGTCCCTGGGGGACTAGCACAGATACGCAGTATTTTGGCCCA	CASSPWGTSTDTQYF	In	VDJ	1	20	0.001084010840108401	0.0013997760358342665	45	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	10	0	6	0	26	38	-1	44	50	TCRBV09,TCRBV12					01,02								CASSPWGTSTDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCCGAAATAGTTTGGGTCACAGATACGCAGTATTTTGGCCCA	CASSPEIVWVTDTQYF	In	VDJ	1	20	0.001084010840108401	0.0013997760358342665	48	TCRBV03						TCRBJ02	TCRBJ02-03	01	4	0	9	2	12	1	26	39	54	51	55		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPEIVWVTDTQYF+TCRBV03-X+TCRBJ02-03	TCRBV03		TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGACGGGCTCGGCATTCACCCCTCCACTTTGGGAAC	CSARRARHSPLHF	In	VDJ	1	20	0.001084010840108401	0.0013997760358342665	39	TCRBV20						TCRBJ01	TCRBJ01-06	01	2	8	0	8	1	5	26	38	43	39	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARRARHSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGCCTGGAATTGAACACTGAAGCTTTCTTTGGACAA	CASSLELNTEAFF	In	VDJ	1	20	0.001084010840108401	0.0013997760358342665	39	TCRBV24						TCRBJ01	TCRBJ01-01	01	7	1	8	0	3	2	24	35	41	38	43		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLELNTEAFF+TCRBV24-X+TCRBJ01-01	TCRBV24		TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GAGGGACTCRGCCSTKTATCTYTRCGCCAGCAGCGATCGGACAGGCGGAACTAATGAAAAACTGTTTTTTGGCAGT	XASSDRTGGTNEKLFF	In	VDJ	1	20	0.001084010840108401	0.0013997760358342665	48	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	1	4	1	4	3	19	31	42	35	45	TCRBV05,TCRBV07,TCRBV17													XASSDRTGGTNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TCSCTCCCARACATCTGTGTAYTTCTGYGCCAGCATGTTAGTACAGTCACCCCTCCACTTTGGGAAC	CASMLVQSPLHF	In	VDJ	1	20	0.001084010840108401	0.0013997760358342665	36	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	7	3	5	10	7	0	25	35	-1	42	46	TCRBV06,TCRBV10													CASMLVQSPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCGGCCGGGCCCCTTCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	21	0.0011382113821138211		49	TCRBV03						TCRBJ01	TCRBJ01-02	01	5	8	0	4	4	13	26	38	46	42	59		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV03-X+TCRBJ01-02	TCRBV03		TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CACCWMCCAGACATCTRTGTACYTSTGTGCCAGCAGGCCTGGAGGGTTTGGAACGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	21	0.0011382113821138211		44	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-04	01	6	10	0	8	4	8	23	34	44	38	52	TCRBV06,TCRBV28													X+X+TCRBJ01-04	unresolved	TCRBD02-01*02	TCRBJ01-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGCGCGGGAGTCCTATGGCTACACCTTCGGTTCG	CASSLARESYGYTF	In	VDJ	1	21	0.0011382113821138211	0.0014697648376259798	42				TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	0	7	2	4	0	2	18	-1	42	35	44	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03												CASSLARESYGYTF+X+TCRBJ01-02		TCRBD02-01*02	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTGTTGTCTAGACTAGTTGTGGATGAGCAGTTCTTCGGGCCA	CASSLLSRLVVDEQFF	In	VDJ	1	22	0.0011924119241192412	0.001539753639417693	48	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	3	2	8	8	8	6	26	40	54	48	60		TCRBV12-03,TCRBV12-04				01,02								CASSLLSRLVVDEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACCCAGGGACTCRGCYGTGTATKTYTGTGCCAGCAGCCCAACTCCGGGACATCTTCCACCCCTCCACTTTGGGAAC	CASSPTPGHLPPLHF	In	VDJ	1	22	0.0011924119241192412	0.001539753639417693	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	0	6	11	8	5	18	30	44	38	49	TCRBV11,TCRBV12													CASSPTPGHLPPLHF+X+TCRBJ01-06	unresolved	TCRBD01-01*01	TCRBJ01-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGTGCTACCGGGGGGGTTCAAGAGACCCAGTACTTCGGGCCA	CASSATGGVQETQYF	In	VDJ	1	22	0.0011924119241192412	0.001539753639417693	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	8	0	2	6	2	19	30	44	36	46	TCRBV05,TCRBV07													CASSATGGVQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGAACACGGCCGAGAAGCTTTCTTTGGACAA	CASSQEHGREAFF	In	VDJ	1	23	0.0012466124661246612	0.0016097424412094064	39	unresolved						TCRBJ01	TCRBJ01-01	01	0	3	6	8	0	7	23	-1	43	40	50	TCRBV01,TCRBV04			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQEHGREAFF+X+TCRBJ01-01	unresolved		TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCARCCAGACMKMTCTKTACYWCTGTGCCAGCAGTTTAAGGGGCCACCTGAAGCTTTCTTTGGACAA		Out	VDJ	1	23	0.0012466124661246612		38	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	5	2	6	3	4	24	36	44	39	48	TCRBV08,TCRBV24													X+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CGACTCGGCTGTGTATCTCTGTGCCAGCAGCTCAGGGCCGGGACAGGGGCCCACTCTCGAGCAGTTCTTCGGGCCA	CASSSGPGQGPTLEQFF	In	VDJ	1	23	0.0012466124661246612	0.0016097424412094064	51	TCRBV07			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	1	0	2	10	4	9	19	35	49	39	58		TCRBV07-01,TCRBV07-05												CASSSGPGQGPTLEQFF+TCRBV07-X+TCRBJ02-01	TCRBV07	TCRBD01-01*01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACYSRGGGACTCAGCTKTGTATTTYTGTGCCAGCAGCGCGCCCGGACTAGCGGGGGGCGGGGAGCTGTTTTTTGGAGAA	CASSAPGLAGGGELFF	In	VDJ	1	24	0.0013008130081300813	0.0016797312430011197	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	1	1	7	7	0	26	37	-1	44	58	TCRBV09,TCRBV12													CASSAPGLAGGGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01*01	TCRBJ02-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTCTGCAGTACGGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	24	0.0013008130081300813		46	TCRBV20						TCRBJ01	TCRBJ01-02	01	0	4	5	2	6	5	26	40	49	46	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-02	TCRBV20		TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTGTACAGGTCGAATCGACCTACGAGCAGTACTTCGGGCCG	CSAVQVESTYEQYF	In	VDJ	1	24	0.0013008130081300813	0.0016797312430011197	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	5	3	4	2	2	9	26	35	42	37	51		TCRBV20-01,TCRBV20-or09_02												CSAVQVESTYEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCARCCAGACMKMTCTKTACYWCTGTGCCAGCAGTTTATCGATCGCAGGGCTTATGAACACTGAAGCTTTCTTTGGACAA	CASSLSIAGLMNTEAFF	In	VDJ	1	24	0.0013008130081300813	0.0016797312430011197	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	4	3	0	12	4	22	32	49	44	53	TCRBV08,TCRBV24,TCRBV27													CASSLSIAGLMNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCGGCCATGTATCKCTGTGCCAGCAGCCAAGCGAACAGGGTGAACACTGAAGCTTTCTTTGGACAA	CASSQANRVNTEAFF	In	VDJ	1	24	0.0013008130081300813	0.0016797312430011197	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	3	3	0	7	0	18	30	-1	37	43	TCRBV07,TCRBV11													CASSQANRVNTEAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATAGGACTCGTCGGGCCGGGGAGCTGTTTTTTGGAGAA	CASSQDRTRRAGELFF	In	VDJ	1	24	0.0013008130081300813	0.0016797312430011197	48				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	0	1	10	6	2	7	18	35	42	37	49	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03				01,02								CASSQDRTRRAGELFF+X+TCRBJ02-02		TCRBD02-01	TCRBJ02-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCTTCCCATGGCCAGGGAGACCCAGTACTTCGGGCCA	CASSLPMARETQYF	In	VDJ	1	24	0.0013008130081300813	0.0016797312430011197	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	5	4	4	5	11	0	18	30	-1	41	45	TCRBV07,TCRBV11													CASSLPMARETQYF+X+TCRBJ02-05	unresolved	TCRBD01-01*01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGTCCCGAGGAGCGGGGGGCTCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	24	0.0013008130081300813		49	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	6	6	1	2	8	2	18	29	46	37	48	TCRBV07,TCRBV11													X+X+TCRBJ02-03	unresolved	TCRBD02-01*01	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCCCTGGGTTATGAGCAGTTCTTCGGGCCA	CASSPLGYEQFF	In	VDJ	1	25	0.0013550135501355014	0.0017497200447928333	36	TCRBV12						TCRBJ02	TCRBJ02-01	01	6	0	9	8	6	2	26	37	46	43	48		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPLGYEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12		TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCTTAGCGGGGGCCGCCAAGAGACCCAGTACTTCGGGCCA	CASSLSGGRQETQYF	In	VDJ	1	25	0.0013550135501355014	0.0017497200447928333	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	5	2	1	3	3	26	37	49	40	52		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASSLSGGRQETQYF+TCRBV12-X+TCRBJ02-05	TCRBV12	TCRBD02-01*01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGGGATAGCGGGGGCCGTTCCTACGAGCAGTACTTCGGGCCG	CASRDSGGRSYEQYF	In	VDJ	1	25	0.0013550135501355014	0.0017497200447928333	45	TCRBV12			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	6	5	2	1	3	4	26	37	49	40	53		TCRBV12-03,TCRBV12-04,TCRBV12-05												CASRDSGGRSYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01*01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GRGACWCGGCMCTSTATCTCTGYGCCAGCAGCTGGGGCAGTGGCAAAAACATTCAGTACTTCGGCGCC	CASSWGSGKNIQYF	In	VDJ	1	25	0.0013550135501355014	0.0017497200447928333	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	7	0	3	0	5	19	-1	37	32	42	TCRBV05,TCRBV23													CASSWGSGKNIQYF+X+TCRBJ02-04	unresolved	TCRBD01-01*01	TCRBJ02-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATGAGGGGGGATTACACACCATATATTTTGGAGAG	CSARDEGGLHTIYF	In	VDJ	1	26	0.0014092140921409214	0.0018197088465845466	42	TCRBV20						TCRBJ01	TCRBJ01-03	01	0	5	1	8	2	6	26	40	48	42	54		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDEGGLHTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATGATGGAACAGGGGACTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	1	26	0.0014092140921409214		53	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	3	3	2	0	6	3	24	39	52	45	55		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-04	TCRBV24	TCRBD01-01*01	TCRBJ02-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGAATTAGGGCGCGGGGTGTATGGCTACACCTTCGGTTCG	CASSELGRGVYGYTF	In	VDJ	1	26	0.0014092140921409214	0.0018197088465845466	45	TCRBV06			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-02	01	2	7	3	5	7	2	23	38	51	45	53		TCRBV06-01,TCRBV06-08												CASSELGRGVYGYTF+TCRBV06-X+TCRBJ01-02	TCRBV06	TCRBD02-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCATAAGGTTCCGATGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	27	0.0014634146341463415		50	TCRBV12						TCRBJ01	TCRBJ01-02	01	4	2	7	4	18	0	26	39	-1	57	60		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV12-X+TCRBJ01-02	TCRBV12		TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATGACTAGCGAGAGACCCAGTACTTCGGGCCA	CASSQDD*RETQYF	Stop	VDJ	1	27	0.0014634146341463415		42	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	2	6	4	1	0	26	43	-1	44	52		TCRBV03-01,TCRBV03-02				01,02								CASSQDD*RETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD02-01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCGAGACAGTGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	27	0.0014634146341463415		35	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	2	4	5	2	0	2	26	-1	41	38	43		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTTTAGGGCAGGGTTTAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	27	0.0014634146341463415		52	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	1	4	3	0	6	5	24	41	52	47	57		TCRBV24-01,TCRBV24-or09_02												X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD01-01*01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTTTATAAGAGAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	27	0.0014634146341463415		37	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	6	11	2	5	6	0	24	36	-1	42	45	TCRBV06,TCRBV24													X+X+TCRBJ02-03	unresolved	TCRBD02-01*02	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCGCCCCACCCCCCGGGGCCAACGTCCTGACTTTCGGGGCC	CASAPPPGANVLTF	In	VDJ	1	27	0.0014634146341463415	0.0018896976483762599	42	unresolved						TCRBJ02	TCRBJ02-06	01	7	3	7	4	5	5	19	28	35	33	40	TCRBV05,TCRBV07			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASAPPPGANVLTF+X+TCRBJ02-06	unresolved		TCRBJ02-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCCCGGACAGTTGAACACTGAAGCTTTCTTTGGACAA	CSAPGQLNTEAFF	In	VDJ	1	28	0.0015176151761517615	0.001959686450167973	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	5	0	4	1	26	34	44	38	45		TCRBV20-01,TCRBV20-or09_02												CSAPGQLNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGGCGGGGACAGGGGGCCCCGAAAGCTTTCTTTGGACAA	CSARRGQGAPKAFF	In	VDJ	1	28	0.0015176151761517615	0.001959686450167973	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	0	0	9	6	5	26	34	52	40	57		TCRBV20-01,TCRBV20-or09_02												CSARRGQGAPKAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTACAGGGAACGCCGGAAACACCATATATTTTGGAGAG	CSATGNAGNTIYF	In	VDJ	1	28	0.0015176151761517615	0.001959686450167973	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	4	4	3	4	0	6	26	-1	41	36	47		TCRBV20-01,TCRBV20-or09_02												CSATGNAGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20	TCRBD01-01*01	TCRBJ01-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCGACAGGGGGTCCTTGCAACTAATGAAAAACTGTTTTTTGGCAGT	CASSRQGVLATNEKLFF	In	VDJ	1	28	0.0015176151761517615	0.001959686450167973	51	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	1	0	1	6	18	30	40	31	46	TCRBV07,TCRBV11													CASSRQGVLATNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATCTTGGACTAGCGTCCTCCTACAATGAGCAGTTCTTCGGGCCA	CSARDLGLASSYNEQFF	In	VDJ	1	29	0.0015718157181571816	0.0020296752519596865	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	0	1	6	0	4	2	26	40	53	44	55		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLGLASSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20	TCRBD02-01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCAGCTTTCTATGAGTGGATCACCCCTCCACTTTGGGAAC	CSASQLSMSGSPLHF	In	VDJ	1	29	0.0015718157181571816	0.0020296752519596865	45	TCRBV20						TCRBJ01	TCRBJ01-06	01	3	1	8	10	16	0	26	37	-1	53	56		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSASQLSMSGSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20		TCRBJ01-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTAGCCTCAGTACGGAATCAGCCCCAGCATTTTGGTGAT	CASSLASVRNQPQHF	In	VDJ	1	29	0.0015718157181571816	0.0020296752519596865	45							TCRBJ01	TCRBJ01-05	01	0	4	5	4	2	5	18	35	40	37	45	TCRBV07,TCRBV11	TCRBV07-02,TCRBV11-03		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLASVRNQPQHF+X+TCRBJ01-05			TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCTTAGTGCTGGGGGGCCAAAGTTATAATTCACCCCTCCACTTTGGGAAC	CASSLVLGGQSYNSPLHF	In	VDJ	1	29	0.0015718157181571816	0.0020296752519596865	54	TCRBV05						TCRBJ01	TCRBJ01-06	01	2	6	0	4	7	6	19	33	46	40	52		TCRBV05-06,TCRBV05-07		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLVLGGQSYNSPLHF+TCRBV05-X+TCRBJ01-06	TCRBV05		TCRBJ01-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AGCTCCCAGACATCTGTGTACTTCTGTGCCAGCAGTGCCATTCCCGGGAACGAGCAGTACTTCGGGCCG	CASSAIPGNEQYF	In	VDJ	1	30	0.0016260162601626016	0.0020996640537514	39				TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-07	01	4	8	3	5	7	0	24	37	-1	44	49	TCRBV06,TCRBV10	TCRBV06-01,TCRBV10-03												CASSAIPGNEQYF+X+TCRBJ02-07		TCRBD02-01*02	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGCCTATTTAAAACAAGGCAGCCCCAGCATTTTGGTGAT	CATSLFKTRQPQHF	In	VDJ	1	30	0.0016260162601626016	0.0020996640537514	42	TCRBV24						TCRBJ01	TCRBJ01-05	01	7	3	6	7	10	3	24	35	48	45	51		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSLFKTRQPQHF+TCRBV24-X+TCRBJ01-05	TCRBV24		TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACKCRGCCRTGTAYSTSTGTGCCAGCAGCTTAATTAGCGGGGGGTTACAAGAGACCCAGTACTTCGGGCCA	CASSLISGGLQETQYF	In	VDJ	1	30	0.0016260162601626016	0.0020996640537514	48	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	2	5	1	2	2	3	18	33	45	35	48	TCRBV11,TCRBV15													CASSLISGGLQETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01*01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAGGTTACCGACAGCAAACATACGAGCAGTACTTCGGGCCG		Out	VDJ	1	31	0.0016802168021680217		47	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	3	2	5	4	7	6	26	40	52	47	58		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD01-01*01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTGGACTAGCGGGGTTGCAGATACGCAGTATTTTGGCCCA	CSAWTSGVADTQYF	In	VDJ	1	31	0.0016802168021680217	0.002169652855543113	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	1	3	4	1	3	26	35	48	36	51		TCRBV20-01,TCRBV20-or09_02												CSAWTSGVADTQYF+TCRBV20-X+TCRBJ02-03	TCRBV20	TCRBD02-01*01	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTTCCCCAGCGGGGGGGCAAGAGACCCAGTACTTCGGGCCA	CSASPAGGQETQYF	In	VDJ	1	32	0.0017344173441734417	0.0022396416573348264	42	TCRBV20			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	6	0	2	5	0	26	35	-1	40	50		TCRBV20-01,TCRBV20-or09_02												CSASPAGGQETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD02-01*01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGTAGCGGACAGGGGGAGTGGAGAGACCCAGTACTTCGGGCCA	CSVADRGSGETQYF	In	VDJ	1	32	0.0017344173441734417	0.0022396416573348264	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	7	1	1	4	4	5	26	33	47	37	52		TCRBV20-01,TCRBV20-or09_02												CSVADRGSGETQYF+TCRBV20-X+TCRBJ02-05	TCRBV20	TCRBD01-01*01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTTCAGGCAGGGGATTACAGCCCCAGCATTTTGGTGAT	CSSGRGLQPQHF	In	VDJ	1	32	0.0017344173441734417	0.0022396416573348264	36	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	8	4	2	7	5	4	26	32	43	37	47		TCRBV20-01,TCRBV20-or09_02												CSSGRGLQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20	TCRBD01-01*01	TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCAGCCTACAGGGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSLQGANTEAFF	In	VDJ	1	32	0.0017344173441734417	0.0022396416573348264	42	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	3	0	1	2	0	19	31	-1	33	42		TCRBV05-06,TCRBV05-07												CASSLQGANTEAFF+TCRBV05-X+TCRBJ01-01	TCRBV05	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AGCTCCCAGACATCTGTGTAYTTCTGYGCCAGCAGTGAAGGGACAGGGGTACGCGCTTTCTTTGGACAA	CASSEGTGVRAFF	In	VDJ	1	33	0.0017886178861788618	0.0023096304591265398	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	2	11	1	5	23	37	48	38	53	TCRBV06,TCRBV10													CASSEGTGVRAFF+X+TCRBJ01-01	unresolved	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TGTACSCTCYCAGACATCTGTGTAYTTCTGYGCCGCCCTCCTAAGCGACACCGGGGAGCTGTTTTTTGGAGAA	CAALLSDTGELFF	In	VDJ	1	33	0.0017886178861788618	0.0023096304591265398	39	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	11	6	6	3	9	0	23	29	-1	38	42	TCRBV06,TCRBV10					01,02								CAALLSDTGELFF+X+TCRBJ02-02	unresolved	TCRBD02-01	TCRBJ02-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCGGCCCTCTATCTCTGTGCCAGCTCTGACAGGGGGCTGCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	33	0.0017886178861788618		40	TCRBV05			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	0	4	3	2	19	28	41	31	43		TCRBV05-06,TCRBV05-07												X+TCRBV05-X+TCRBJ01-01	TCRBV05	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGGACACCTAATGGCTACACCTTCGGTTCG	CASSLGTPNGYTF	In	VDJ	1	34	0.0018428184281842818	0.002379619260918253	39	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	1	6	6	0	4	26	-1	47	42	51		TCRBV12-03,TCRBV12-04												CASSLGTPNGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCATTGTGCACCGACGGAACTAACTCTCGAGCAATACTTCGGGCCG	CASSHCAPTELTLEQYF	In	VDJ	1	34	0.0018428184281842818	0.002379619260918253	51	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	3	3	9	13	15	12	26	40	59	55	71		TCRBV03-01,TCRBV03-02				01,02								CASSHCAPTELTLEQYF+TCRBV03-X+TCRBJ02-07	TCRBV03	TCRBD02-01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTTAGGGGATCGGACGAGCAGTACTTCGGGCCG	CSARDFRGSDEQYF	In	VDJ	1	34	0.0018428184281842818	0.002379619260918253	42	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	0	5	2	5	4	5	26	40	49	44	54		TCRBV20-01,TCRBV20-or09_02												CSARDFRGSDEQYF+TCRBV20-X+TCRBJ02-07	TCRBV20	TCRBD01-01*01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGGGGTTAGTAGACAGGAAGCTTTCTTTGGACAA	CSARGVSRQEAFF	In	VDJ	1	34	0.0018428184281842818	0.002379619260918253	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	1	2	5	8	9	0	26	39	-1	48	53		TCRBV20-01,TCRBV20-or09_02												CSARGVSRQEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAATCGGAGGGGCGTAAATCCGGAAACACCATATATTTTGGAGAG	CASSQSEGRKSGNTIYF	In	VDJ	1	34	0.0018428184281842818	0.002379619260918253	51	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	0	10	0	4	0	10	20	-1	43	37	53	TCRBV01,TCRBV23													CASSQSEGRKSGNTIYF+X+TCRBJ01-03	unresolved	TCRBD02-01*02	TCRBJ01-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCRGCCMTSTATCKCTGTGCCAGCAGYCCATCGACTAGCAGGGATACGCAGTATTTTGGCCCA	CASSPSTSRDTQYF	In	VDJ	1	34	0.0018428184281842818	0.002379619260918253	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	2	7	6	6	3	19	30	43	36	46	TCRBV05,TCRBV07					01,02								CASSPSTSRDTQYF+X+TCRBJ02-03	unresolved	TCRBD02-01	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTCGTTGCTTCGGGGCTACACCTTCGGTTCG	CSARDSLLRGYTF	In	VDJ	1	35	0.001897018970189702	0.0024496080627099664	39	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	0	8	5	8	10	0	26	40	-1	50	53		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDSLLRGYTF+TCRBV20-X+TCRBJ01-02	TCRBV20	TCRBD02-01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCGGACCGAGGATTGTCACCGGGGAGCTGTTTTTTGGAGAA	CASSGPRIVTGELFF	In	VDJ	1	36	0.001951219512195122	0.0025195968645016797	45	TCRBV12						TCRBJ02	TCRBJ02-02	01	6	1	7	4	1	10	26	37	42	38	52		TCRBV12-03,TCRBV12-04,TCRBV12-05		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGPRIVTGELFF+TCRBV12-X+TCRBJ02-02	TCRBV12		TCRBJ02-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCWMCCAGACAKCTSTKTACTTSTGTGCCAGCAGTCCCCCTTCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	36	0.001951219512195122		37	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	5	4	10	2	4	1	23	35	41	39	42	TCRBV06,TCRBV24					01,02								X+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGAAAGTTGGCAGGGTAATGGCTACACCTTCGGTTCG	CASSQESWQGNGYTF	In	VDJ	1	36	0.001951219512195122	0.0025195968645016797	45				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	3	6	7	2	18	35	47	42	49	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												CASSQESWQGNGYTF+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TGCTGTGTATTTCTGTGCCAGCAGCCAAGATGGGACAGGGGGCGGCCCCTACTCCTCACCAGCCCCAGCATTTTGGTGAT		Out	VDJ	1	36	0.001951219512195122		61	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	0	0	0	7	1	16	13	30	43	31	59		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-05	TCRBV03	TCRBD01-01*01	TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAAGGGGCCCGGGACACCGGGGAGCTGTTTTTTGGAGAA	CSAREGARDTGELFF	In	VDJ	1	37	0.002005420054200542	0.002589585666293393	45	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	0	5	2	3	0	6	26	-1	45	40	51		TCRBV20-01,TCRBV20-or09_02												CSAREGARDTGELFF+TCRBV20-X+TCRBJ02-02	TCRBV20	TCRBD01-01*01	TCRBJ02-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCAATATAGCTCCATTTACACGCACGAAACACCATATATTTTGGAGAG		Out	VDJ	1	38	0.002059620596205962		52	TCRBV03			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-03	01	5	5	7	5	4	15	26	38	46	42	61		TCRBV03-01,TCRBV03-02				01,02								X+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD02-01	TCRBJ01-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGACCATGGTCGCAATCAGCCCCAGCATTTTGGTGAT	CSARDHGRNQPQHF	In	VDJ	1	39	0.002113821138211382	0.0027295632698768196	42	TCRBV20						TCRBJ01	TCRBJ01-05	01	0	0	10	2	4	2	26	40	46	44	48		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARDHGRNQPQHF+TCRBV20-X+TCRBJ01-05	TCRBV20		TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGCCCCCTCGGGTACGAGCAGTACTTCGGGCCG	CASSPLGYEQYF	In	VDJ	1	41	0.0022222222222222222	0.0028695408734602463	36	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	6	8	4	4	6	0	26	37	-1	43	47		TCRBV12-03,TCRBV12-04,TCRBV12-05				01,02								CASSPLGYEQYF+TCRBV12-X+TCRBJ02-07	TCRBV12	TCRBD02-01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCAGCAGTAAGGGACAGGGGGTTGGTGGCTACACCTTCGGTTCG	CASSKGQGVGGYTF	In	VDJ	1	41	0.0022222222222222222	0.0028695408734602463	42	TCRBV24			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	1	7	2	4	24	36	49	38	53		TCRBV24-01,TCRBV24-or09_02												CASSKGQGVGGYTF+TCRBV24-X+TCRBJ01-02	TCRBV24	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
SCTCCCAGACATCTGTGTAYTTSTGYGCCAGCAGTTTGTACGGGTTAGGTGAAAAACTGTTTTTTGGCAGT	CASSLYGLGEKLFF	In	VDJ	1	41	0.0022222222222222222	0.0028695408734602463	42	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	4	8	4	7	4	5	23	36	44	40	49	TCRBV06,TCRBV10					01,02								CASSLYGLGEKLFF+X+TCRBJ01-04	unresolved	TCRBD02-01	TCRBJ01-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCAGCCCAGTCGACAGAAATGAAAAACTGTTTTTTGGCAGT	CASSPVDRNEKLFF	In	VDJ	1	41	0.0022222222222222222	0.0028695408734602463	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	4	2	5	5	6	1	19	31	42	37	43	TCRBV05,TCRBV11													CASSPVDRNEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCCACGGGACAGGGTTTCACCCCTCCACTTTGGGAAC	CASSPRDRVSPLHF	In	VDJ	1	42	0.0022764227642276423	0.0029395296752519596	42	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	4	0	3	9	3	1	26	39	51	42	52		TCRBV03-01,TCRBV03-02												CASSPRDRVSPLHF+TCRBV03-X+TCRBJ01-06	TCRBV03	TCRBD01-01*01	TCRBJ01-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCATCAGTGAACATGGGCCCTCGGGGACTGAAGCTTTCTTTGGACAA	CAISEHGPSGTEAFF	In	VDJ	1	42	0.0022764227642276423	0.0029395296752519596	45	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ01	TCRBJ01-01	01	2	8	3	5	10	0	23	38	-1	48	53	TCRBV06,TCRBV10													CAISEHGPSGTEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTACAGCTTAATGAAAAACTGTTTTTTGGCAGT	CASSLQLNEKLFF	In	VDJ	1	43	0.0023306233062330623	0.003009518477043673	39	TCRBV12						TCRBJ01	TCRBJ01-04	01	2	4	5	4	0	2	26	-1	44	41	46		TCRBV12-03,TCRBV12-04		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLQLNEKLFF+TCRBV12-X+TCRBJ01-04	TCRBV12		TCRBJ01-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTTAGGGAACAGGGGGCTTAGCAATCAGCCCCAGCATTTTGGTGAT	CASSLGNRGLSNQPQHF	In	VDJ	1	43	0.0023306233062330623	0.003009518477043673	51	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	1	3	0	0	3	1	26	42	54	45	55		TCRBV12-03,TCRBV12-04												CASSLGNRGLSNQPQHF+TCRBV12-X+TCRBJ01-05	TCRBV12	TCRBD01-01*01	TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGTCCAGGTACGAACACTGAAGCTTTCTTTGGACAA	CSASPGTNTEAFF	In	VDJ	1	43	0.0023306233062330623	0.003009518477043673	39	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	4	4	1	2	3	26	37	43	39	46		TCRBV20-01,TCRBV20-or09_02												CSASPGTNTEAFF+TCRBV20-X+TCRBJ01-01	TCRBV20	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCACCTTGACTAGCGGACGTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	44	0.0023848238482384824		41	TCRBV24			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	8	2	5	4	4	3	24	34	47	38	50		TCRBV24-01,TCRBV24-or09_02				01,02								X+TCRBV24-X+TCRBJ02-07	TCRBV24	TCRBD02-01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
SCTCCCAGACATCTGTGTAYTTSTGYGCCAGCAGTTACGACAGCATTAATGAAAAACTGTTTTTTGGCAGT	CASSYDSINEKLFF	In	VDJ	1	44	0.0023848238482384824	0.003079507278835386	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	2	5	4	0	3	23	-1	43	38	46	TCRBV06,TCRBV10													CASSYDSINEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ASCTCCCAGACATCTGTGTACTTSTGTGCCACCTCACCTACAGACAGGACCTACGAGCAGTACTTCGGGCCG	CATSPTDRTYEQYF	In	VDJ	1	46	0.0024932249322493225	0.003219484882418813	42	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	10	2	4	2	11	1	24	31	48	42	49	TCRBV06,TCRBV10													CATSPTDRTYEQYF+X+TCRBJ02-07	unresolved	TCRBD01-01*01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATCTACAGGGGCTGGCTACACCTTCGGTTCG		Out	VDJ	1	46	0.0024932249322493225		41				TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	3	2	7	3	1	18	35	45	38	46	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03												X+X+TCRBJ01-02		TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGTGGACAGGTTAGAAACACCATATATTTTGGAGAG	CASGQVRNTIYF	In	VDJ	1	47	0.0025474254742547425	0.003289473684210526	36	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	9	1	4	5	1	3	26	34	42	35	45		TCRBV03-01,TCRBV03-02												CASGQVRNTIYF+TCRBV03-X+TCRBJ01-03	TCRBV03	TCRBD01-01*01	TCRBJ01-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GGACTCGGCCSTSTATSTCTGTGCCAGCTATAGCCCTGCTCGCGAAAGACCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	51	0.0027642276422764228		47	unresolved			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	7	5	7	4	2	16	19	28	34	30	50	TCRBV05,TCRBV11					01,02								X+X+TCRBJ01-02	unresolved	TCRBD02-01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCRTGTATSKCTGTGCCAGCAGCCCCTCCCTTTTGTCTGGTGAAAAACTGTTTTTTGGCAGT	CASSPSLLSGEKLFF	In	VDJ	1	53	0.002872628726287263	0.0037094064949608064	45	unresolved						TCRBJ01	TCRBJ01-04	01	5	0	10	7	15	0	18	30	-1	45	47	TCRBV07,TCRBV11			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPSLLSGEKLFF+X+TCRBJ01-04	unresolved		TCRBJ01-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTTCCTTACGCCCAGGGGGAAGAGGCTACACCTTCGGTTCG	CASSSLRPGGRGYTF	In	VDJ	2	54	0.002926829268292683	0.0037793952967525198	45	TCRBV12			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	4	4	1	8	9	4	26	39	55	48	59		TCRBV12-03,TCRBV12-04												CASSSLRPGGRGYTF+TCRBV12-X+TCRBJ01-02	TCRBV12	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCCCGGACCGTTGCTGGAAACACCATATATTTTGGAGAG	CSARTVAGNTIYF	In	VDJ	2	54	0.002926829268292683	0.0037793952967525198	39	TCRBV20						TCRBJ01	TCRBJ01-03	01	6	1	7	2	2	5	26	34	40	36	45		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARTVAGNTIYF+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ACGACTCGGCCSTGTATCTCTGTGCCAGCAGCCTACAAAGGGAGGCTGAAGCTTTCTTTGGACAA	CASSLQREAEAFF	In	VDJ	2	56	0.003035230352303523	0.003919372900335946	39	unresolved			TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	9	1	6	7	0	18	30	-1	37	43	TCRBV05,TCRBV07													CASSLQREAEAFF+X+TCRBJ01-01	unresolved	TCRBD02-01*02	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGAGGTTTGTTAGTACAGTAAATAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	2	57	0.003089430894308943		52	TCRBV20			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	0	3	5	4	11	4	26	40	55	51	59		TCRBV20-01,TCRBV20-or09_02												X+TCRBV20-X+TCRBJ01-04	TCRBV20	TCRBD01-01*01	TCRBJ01-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGGAATAATTTTGGTTGGTCCTACAATGAGCAGTTCTTCGGGCCA	CSARNNFGWSYNEQFF	In	VDJ	2	59	0.003197831978319783	0.004129339305711086	48	TCRBV20						TCRBJ02	TCRBJ02-01	01	3	0	10	1	10	4	26	37	49	47	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CSARNNFGWSYNEQFF+TCRBV20-X+TCRBJ02-01	TCRBV20		TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAACCCCACCAGGGAGTGGTGGAAACACCATATATTTTGGAGAG		Out	VDJ	2	64	0.0034688346883468835		46	TCRBV20						TCRBJ01	TCRBJ01-03	01	4	4	3	3	7	5	26	36	48	43	53		TCRBV20-01,TCRBV20-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV20-X+TCRBJ01-03	TCRBV20		TCRBJ01-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CGACTCGGCYGTGTATSTCTGTGCCAGCAGCGCCCAGACAGGGGCCGAGGAAAAACTGTTTTTTGGCAGT	CASSAQTGAEEKLFF	In	VDJ	2	64	0.0034688346883468835	0.004479283314669653	45	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	2	2	8	5	5	18	30	43	35	48	TCRBV07,TCRBV11													CASSAQTGAEEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCAGTATCTACCCCCTCAACAATGAGCAGTTCTTCGGGCCA	CASSIYPLNNEQFF	In	VDJ	2	65	0.0035230352303523035	0.004549272116461366	42	TCRBV12			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	9	5	2	8	26	38	43	40	51		TCRBV12-03,TCRBV12-04				01,02								CASSIYPLNNEQFF+TCRBV12-X+TCRBJ02-01	TCRBV12	TCRBD02-01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAGGGGACTAGCGGGGGTCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	2	65	0.0035230352303523035		49	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	3	0	2	0	1	1	23	37	52	38	53	TCRBV01,TCRBV04													X+X+TCRBJ02-07	unresolved	TCRBD02-01*01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGATATCCAGGGGAACAGAGGACACTGAAGCTTTCTTTGGACAA		Out	VDJ	2	66	0.0035772357723577236		52	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	4	2	3	4	8	26	43	53	47	61		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ01-01	TCRBV03	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCGGGACAGGGCCGACCAAGAGACCCAGTACTTCGGGCCA	CASSRDRADQETQYF	In	VDJ	2	68	0.0036856368563685637	0.004759238521836506	45	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	4	0	3	0	0	3	26	-1	48	39	51		TCRBV03-01,TCRBV03-02												CASSRDRADQETQYF+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGATCCTCACGGAGAGACCCAGTACTTCGGGCCA	CASSQDPHGETQYF	In	VDJ	2	68	0.0036856368563685637	0.004759238521836506	42				TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	0	8	5	4	6	0	18	35	-1	41	44	TCRBV04,TCRBV11	TCRBV04-02,TCRBV11-03				01,02								CASSQDPHGETQYF+X+TCRBJ02-05		TCRBD02-01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
TYRGGRGACWCAGCWYKGTATTTCTGTGCCAGCAGCATAGAGCCGGGACTCCGTAACCCGGAGACCCAGTACTTCGGGCCA	CASSIEPGLRNPETQYF	In	VDJ	2	86	0.004661246612466125	0.006019036954087346	51	unresolved			TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	4	0	10	5	7	10	24	37	50	44	60	TCRBV09,TCRBV21					01,02								CASSIEPGLRNPETQYF+X+TCRBJ02-05	unresolved	TCRBD02-01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ATCCTGAAGACAGCAGCTTCTACATCTGCAGTGCTAGAGATTTGGGACTAGGGGGGTTAGGGTCACCCCTCCACTTTGGGAAC	CSARDLGLGGLGSPLHF	In	VDJ	2	88	0.004769647696476965	0.006159014557670772	51	TCRBV20			TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-06	01	0	0	8	10	3	11	26	40	51	43	62		TCRBV20-01,TCRBV20-or09_02				01,02								CSARDLGLGGLGSPLHF+TCRBV20-X+TCRBJ01-06	TCRBV20	TCRBD02-01	TCRBJ01-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
ARRRRGACTCAGCYGYGTATCTCTRCGCCAGCAGCCAAAGCGGGGAGGACATTCAGTACTTCGGCGCC	XASSQSGEDIQYF	In	VDJ	4	149	0.008075880758807589	0.010428331466965285	39	unresolved			TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-04	01	2	6	3	8	0	3	22	-1	44	37	47	TCRBV01,TCRBV04													XASSQSGEDIQYF+X+TCRBJ02-04	unresolved	TCRBD02-01*01	TCRBJ02-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCCAACCAGACAGCTCTTTACTTCTGTGCCACCAGTGATTTGGCCAATGAGCAGTTCTTCGGGCCA	CATSDLANEQFF	In	VDJ	5	173	0.00937669376693767	0.012108062709966406	36	TCRBV24						TCRBJ02	TCRBJ02-01	01	0	10	0	6	0	0	24	-1	-1	42	44		TCRBV24-01,TCRBV24-or09_02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSDLANEQFF+TCRBV24-X+TCRBJ02-01	TCRBV24		TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAAGTACCTACCGGGGAGCTGTTTTTTGGAGAA	CASSQVPTGELFF	In	VDJ	5	186	0.010081300813008131	0.013017917133258679	39	TCRBV03						TCRBJ02	TCRBJ02-02	01	1	3	7	5	1	2	26	42	45	43	47		TCRBV03-01,TCRBV03-02		TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQVPTGELFF+TCRBV03-X+TCRBJ02-02	TCRBV03		TCRBJ02-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
MAGAAGACTCAGCYSYGTATCTCTGCGCCAGCAGCCAAGGGACAGGGGAAAAACTGTTTTTTGGCAGT	CASSQGTGEKLFF	In	VDJ	5	190	0.010298102981029811	0.013297872340425532	39	unresolved			TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	1	1	3	8	0	0	23	-1	-1	39	47	TCRBV01,TCRBV04													CASSQGTGEKLFF+X+TCRBJ01-04	unresolved	TCRBD01-01*01	TCRBJ01-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AAGRAGACWCRGCWSYGTATCTCTGCGCCAGCAGCCAAGATCTGGGACGCCACTCTGGAAACACCATATATTTTGGAGAG	CASSQDLGRHSGNTIYF	In	VDJ	6	201	0.010894308943089431	0.014067749160134379	51	unresolved						TCRBJ01	TCRBJ01-03	01	2	0	7	0	5	4	20	35	45	40	49	TCRBV01,TCRBV23			TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDLGRHSGNTIYF+X+TCRBJ01-03	unresolved		TCRBJ01-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AGCTTGGTGACTCTGCTGTGTATTTCTGTGCCAGCAGCCAATCTTTGACAGATTTCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	6	217	0.011761517615176152		47	TCRBV03			TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	2	2	5	2	5	4	26	41	51	46	55		TCRBV03-01,TCRBV03-02												X+TCRBV03-X+TCRBJ02-05	TCRBV03	TCRBD01-01*01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGATTTTCTGGGGAGACTTTACCCCTCTGGAAACACCATATATTTTGGAGAG	CASSQDFLGRLYPSGNTIYF	In	VDJ	1	25	0.0013550135501355014	0.0017497200447928333	60	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	0	9	2	0	7	9	21	38	50	45	59													Vb 7.1	CASSQDFLGRLYPSGNTIYF+TCRBV04-01+TCRBJ01-03	TCRBV04-01*01	TCRBD02-01*02	TCRBJ01-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAAAACAGGGGGCGCGGGGTGAAAAACTGTTTTTTGGCAGT	YASSQKQGARGEKLFF	In	VDJ	1	29	0.0015718157181571816	0.0020296752519596865	48	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	2	3	0	7	2	6	22	37	48	39	54													Vb 7.1	YASSQKQGARGEKLFF+TCRBV04-01+TCRBJ01-04	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GAGGGACTCAGCCGTGTATCTCTACGCCAGCAGCCAAGATCTGGACAGGGGTATGAACACTGAAGCTTTCTTTGGACAA	YASSQDLDRGMNTEAFF	In	VDJ	1	34	0.0018428184281842818	0.002379619260918253	51	TCRBV04	TCRBV04-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	2	0	3	2	22	39	51	42	53													Vb 7.1	YASSQDLDRGMNTEAFF+TCRBV04-01+TCRBJ01-01	TCRBV04-01*01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAGAAGACTCAGCCCTGTATCTCTGCGCCAGCAGCCAAGAGAACCCATTCGAGTTGGAGACCCAGTACTTCGGGCCA	CASSQENPFELETQYF	In	VDJ	1	42	0.0022764227642276423	0.0029395296752519596	48	TCRBV04	TCRBV04-01	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	0	11	2	5	10	3	23	40	53	50	56													Vb 7.1	CASSQENPFELETQYF+TCRBV04-01+TCRBJ02-05	TCRBV04-01*01	TCRBD02-01*02	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCTCCCAGACATCTGTATATTTCTGCGCCAGCAAGGAGGGGAATGCGCAGTATTTTGGCCCA	CASKEGNAQYF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	33	TCRBV10	TCRBV10-01		TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	7	10	0	10	1	5	26	36	43	37	48			01,02										Vb 12	CASKEGNAQYF+TCRBV10-01+TCRBJ02-03	TCRBV10-01	TCRBD02-01*02	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGGACAGGGCTGTCACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	17	9.214092140921409E-4		38	TCRBV12	TCRBV12-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	2	3	4	0	4	22	-1	40	33	44														X+TCRBV12-01+TCRBJ01-01	TCRBV12-01*01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CAGGGACTTGGGCCTATATTTCTGTGCCAGCAGCTGATGGGCGGGGGTTGGGATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	21	0.0011382113821138211		44	TCRBV12	TCRBV12-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	7	2	8	5	5	22	35	47	40	52														X+TCRBV12-01+TCRBJ02-01	TCRBV12-01*01	TCRBD02-01*01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACGCAGCCATGTACCTGTGTGCCACCAGAAAAGTCCTAAAGGACACCGGGGAGCTGTTTTTTGGAGAA	CATRKVLKDTGELFF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	45	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-02	01	6	5	4	3	11	0	18	29	-1	40	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATRKVLKDTGELFF+TCRBV15-01+TCRBJ02-02	TCRBV15-01*01		TCRBJ02-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGAGCGACGGCCCTCTGGAAACACCATATATTTTGGAGAG	CATSRERRPSGNTIYF	In	VDJ	1	11	5.962059620596206E-4	7.698768197088465E-4	48	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-03	01	0	2	7	0	2	4	18	35	40	37	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRERRPSGNTIYF+TCRBV15-01+TCRBJ01-03	TCRBV15-01*01		TCRBJ01-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTAATGGACCACGGAGATACGCAGTATTTTGGCCCA	CATSRVMDHGDTQYF	In	VDJ	1	12	6.504065040650406E-4	8.398656215005599E-4	45	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-03	01	1	1	7	5	4	5	18	34	42	38	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRVMDHGDTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01		TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACGCAGCCATGTACCTGTGTGCCAGCAGCTTGTCTTAACGGGGGGACAGCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSLS*RGDSSYNEQFF	Stop	VDJ	1	15	8.130081300813008E-4		54	TCRBV15	TCRBV15-01	01				TCRBJ02	TCRBJ02-01	01	5	0	5	0	13	0	18	30	-1	43	50				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSLS*RGDSSYNEQFF+TCRBV15-01+TCRBJ02-01	TCRBV15-01*01		TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATGGTTGGACCAGGACAGAGAACCTTGAAGCTTTCTTTGGACAA	CATSRDGWTRTENLEAFF	In	VDJ	1	23	0.0012466124661246612	0.0016097424412094064	54	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	1	5	7	11	7	18	35	52	46	59														CATSRDGWTRTENLEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACGCAGCCATGTACCTGTGTGCCAGCAGCTTAATGCGGTACGCAGATACGCAGTATTTTGGCCCA	CASSLMRYADTQYF	In	VDJ	1	27	0.0014634146341463415	0.0018896976483762599	42	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	7	5	4	5	4	18	30	39	35	43						01,02								CASSLMRYADTQYF+TCRBV15-01+TCRBJ02-03	TCRBV15-01*01	TCRBD02-01	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCGGCTAGCGGGGCCCGAGCAGTACTTCGGGCCG	CATSRDRLAGPEQYF	In	VDJ	1	35	0.001897018970189702	0.0024496080627099664	45	TCRBV15	TCRBV15-01	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	0	4	3	6	4	2	18	35	48	39	50														CATSRDRLAGPEQYF+TCRBV15-01+TCRBJ02-07	TCRBV15-01*01	TCRBD02-01*01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGTCGCCAGGGCAGGTGGCTACACCTTCGGTTCG	CATSRVARAGGYTF	In	VDJ	1	36	0.001951219512195122	0.0025195968645016797	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	1	4	3	7	4	4	18	34	43	38	47														CATSRVARAGGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATATGGCAGGGGATGGCTACACCTTCGGTTCG	CATSRDMAGDGYTF	In	VDJ	1	42	0.0022764227642276423	0.0029395296752519596	42	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	0	4	2	6	5	0	18	35	-1	40	46														CATSRDMAGDGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCAGAGATCGGAGGGGGACCACTGAAGCTTTCTTTGGACAA	CATSRDRRGTTEAFF	In	VDJ	3	94	0.005094850948509485	0.006578947368421052	45	TCRBV15	TCRBV15-01	01				TCRBJ01	TCRBJ01-01	01	0	5	1	4	4	2	18	35	45	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CATSRDRRGTTEAFF+TCRBV15-01+TCRBJ01-01	TCRBV15-01*01		TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACGCAGCCATGTACCTGTGTGCCACCAGCCCCCAGGTCCGACAGGGCCTCGGCTACACCTTCGGTTCG	CATSPQVRQGLGYTF	In	VDJ	3	104	0.005636856368563686	0.007278835386338186	45	TCRBV15	TCRBV15-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	2	3	8	10	4	18	30	47	40	51														CATSPQVRQGLGYTF+TCRBV15-01+TCRBJ01-02	TCRBV15-01*01	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGACTAGCGGGGGGAGCTCCTACGAGCAGTACTTCGGGCCG	CASSLGTSGGSSYEQYF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-07	01	1	1	1	0	0	2	18	-1	48	34	50														CASSLGTSGGSSYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTCGGAAGGGCGCCCCTAAGCTGACTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	10	5.420054200542005E-4		55	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-07	01	3	5	3	0	4	14	18	32	40	36	54				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01		TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCTAGCGGTACCCTCCTACAATGAGCAGTTCTTCGGGCCA		Out	VDJ	1	13	7.046070460704607E-4		47	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	5	4	5	0	2	4	18	30	39	32	43						01,02								X+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCATTGGGAAGGACAGGGGCCAACGTCCTGACTTTCGGGGCC	CASSSLGRTGANVLTF	In	VDJ	1	16	8.672086720867209E-4	0.0011198208286674132	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	4	1	6	4	9	0	18	31	-1	40	45														CASSSLGRTGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCATCACCACGACAGGGGGCACTGAAGCTTTCTTTGGACAA	CASSITTTGGTEAFF	In	VDJ	1	17	9.214092140921409E-4	0.0011898096304591265	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	2	1	4	8	0	18	30	-1	38	47														CASSITTTGGTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATSTCTGTGCCAGCAGCTTATCCCGGACTAGCGGGGGGTACAATGAGCAGTTCTTCGGGCCA	CASSLSRTSGGYNEQFF	In	VDJ	1	17	9.214092140921409E-4	0.0011898096304591265	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	2	1	1	4	4	0	18	33	-1	37	51														CASSLSRTSGGYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTAGGGAGTACCTTAACTATGGCTACACYTTCGGTTCG	CASSFREYLNYGYTF	In	VDJ	1	18	9.75609756097561E-4	0.0012597984322508398	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	3	9	2	17	2	21	18	32	39	34	60														CASSFREYLNYGYTF+TCRBV11-03+TCRBJ01-02	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGATCCTAGCGGGGGCAATGAGCAGTTCTTCGGGCCA	CASSLDPSGGNEQFF	In	VDJ	1	22	0.0011924119241192412	0.001539753639417693	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	4	2	6	2	0	18	35	-1	37	47														CASSLDPSGGNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGATCGGGTGGACAGGGACCCACAGATACGCAGTATTTTGGCCCA	CASRSGGQGPTDTQYF	In	VDJ	1	23	0.0012466124661246612	0.0016097424412094064	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	6	1	3	2	7	3	18	29	44	36	47														CASRSGGQGPTDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTCAGGCCAGGGGGAGGGCCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSFRPGGGPGANVLTF	In	VDJ	1	28	0.0015176151761517615	0.001959686450167973	54	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-06	01	3	4	1	2	5	5	18	32	44	37	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSFRPGGGPGANVLTF+TCRBV11-03+TCRBJ02-06	TCRBV11-03*01		TCRBJ02-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGAGTGGTCCGTATAACACTGAAGCTTTCTTTGGACAA		Out	VDJ	1	29	0.0015718157181571816		46	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-01	01	0	0	10	2	2	7	18	35	39	37	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01		TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAATCACAGGGGGGGTGGTACAATGAGCAGTTCTTCGGGCCA	CASSQSQGGWYNEQFF	In	VDJ	1	32	0.0017344173441734417	0.0022396416573348264	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-01	01	5	3	1	4	5	5	18	30	43	35	48														CASSQSQGGWYNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAGACGGCTAGCGCCTCCTACGAGCAGTACTTCGGGCCG	CASSQTASASYEQYF	In	VDJ	1	32	0.0017344173441734417	0.0022396416573348264	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	5	4	6	0	7	1	18	30	43	37	44						01,02								CASSQTASASYEQYF+TCRBV11-03+TCRBJ02-07	TCRBV11-03*01	TCRBD02-01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCTCGTCCTACCGGGACTGGGATACGATACGCAGTATTTTGGCCCA	CASSLVLPGLGYDTQYF	In	VDJ	1	32	0.0017344173441734417	0.0022396416573348264	51	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	0	10	6	11	7	18	30	47	41	54						01,02								CASSLVLPGLGYDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAACCAAGTTGTCATTATTCCGGGACTAGCGGATAACCCAGTACTTCGGGCCA	CASSLTKLSLFRD*RITQYF	Stop	VDJ	1	35	0.001897018970189702		60	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-05	01	2	0	5	8	19	3	18	33	63	52	66						01,02								CASSLTKLSLFRD*RITQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTTTGGCACAGAAGGTCTGGGGAGCTTTYTTTGGACAA	CASSSLAQKVWGAFF	In	VDJ	1	36	0.001951219512195122	0.0025195968645016797	45	TCRBV11	TCRBV11-03	01	unresolved			TCRBJ01	TCRBJ01-01	01	4	9	2	17	19	5	18	31	55	50	60				TCRBD01,TCRBD02										CASSSLAQKVWGAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	unresolved	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTTGGCTAGCGGGATAAGAGACCCAGTACTTCGGGCCA	CASSFWLAG*ETQYF	Stop	VDJ	1	36	0.001951219512195122		45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-05	01	3	4	3	3	4	1	18	32	45	36	46														CASSFWLAG*ETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*02	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCGTCGGAGGTACGGGAAACACCATATATTTTGGAGAG	CASSSVGGTGNTIYF	In	VDJ	1	38	0.002059620596205962	0.0026595744680851063	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-03	01	4	10	1	4	5	4	18	31	41	36	45														CASSSVGGTGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01	TCRBD02-01*02	TCRBJ01-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCCTCCCTAGCGGGGAGGGTCAATGAGCAGTTCTTCGGGCCA	CASSSSLAGRVNEQFF	In	VDJ	1	38	0.002059620596205962	0.0026595744680851063	48	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	4	4	3	6	5	5	18	31	45	36	50														CASSSSLAGRVNEQFF+TCRBV11-03+TCRBJ02-01	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGAAGGGCAGCGACCCAAGAGACCCAGTACTTCGGGCCA	CASSGRAATQETQYF	In	VDJ	1	42	0.0022764227642276423	0.0029395296752519596	45	TCRBV11	TCRBV11-03	01				TCRBJ02	TCRBJ02-05	01	5	5	3	1	3	7	18	30	37	33	44				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGRAATQETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01		TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAACCGGAGGGCGGGGGGGAACCAAGAGACCCAGTACTTCGGGCCA		Out	VDJ	1	45	0.0024390243902439024		52	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	5	7	0	0	10	1	18	30	49	40	50														X+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCTCTCCCCAGGGGGCGCGTACCGGGGAGCTGTTTTTTGGAGAA	CASSPQGARTGELFF	In	VDJ	1	46	0.0024932249322493225	0.003219484882418813	45	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	8	4	0	5	6	4	18	27	41	33	45														CASSPQGARTGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCCCTCTTTCCTAGAGACCGACACGCAGTATTTTGGCCCA	CASSPSFLETDTQYF	In	VDJ	1	47	0.0025474254742547425	0.003289473684210526	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-03	01	5	4	8	9	9	8	18	30	43	39	51						01,02								CASSPSFLETDTQYF+TCRBV11-03+TCRBJ02-03	TCRBV11-03*01	TCRBD02-01	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCCAAGCAGGGACGAAAAGCTCTGGAAACACCATATATTTTGGAGAG	CASSQAGTKSSGNTIYF	In	VDJ	2	56	0.003035230352303523	0.003919372900335946	51	TCRBV11	TCRBV11-03	01				TCRBJ01	TCRBJ01-03	01	5	0	7	0	6	6	18	30	41	36	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQAGTKSSGNTIYF+TCRBV11-03+TCRBJ01-03	TCRBV11-03*01		TCRBJ01-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCGGCCACGTCTTCCATGAAAAACTGTTTTTTGGCAGT	CASSGHVFHEKLFF	In	VDJ	2	66	0.0035772357723577236	0.0046192609182530795	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	5	9	0	6	0	10	18	-1	33	30	43														CASSGHVFHEKLFF+TCRBV11-03+TCRBJ01-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTTGGGGGACAGGGGGCTAACACTGAAGCTTTCTTTGGACAA	CASSFGGQGANTEAFF	In	VDJ	2	69	0.0037398373983739837	0.00482922732362822	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	0	0	2	3	1	18	32	47	35	48														CASSFGGQGANTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGTCCTCTGCAGGGAACAGGGTGGCTTTCTTTGGACAA	CASRSSAGNRVAFF	In	VDJ	2	70	0.003794037940379404	0.004899216125419933	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	3	11	14	2	18	29	49	43	51														CASRSSAGNRVAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTTAGGGTGGCAGACAGGGAGAAACATTCAGTACTTCGGCGCC	CASSLGWQTGRNIQYF	In	VDJ	2	74	0.004010840108401084	0.005179171332586786	48	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-04	01	1	2	3	6	7	2	18	34	48	41	50														CASSLGWQTGRNIQYF+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD01-01*01	TCRBJ02-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGCGCGGGGGCTCAACGGAGACCCAGTACTTCGGGCCA	CASRRGGSTETQYF	In	VDJ	3	96	0.005203252032520325	0.006718924972004479	42	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	6	7	2	5	2	7	18	29	38	31	45														CASRRGGSTETQYF+TCRBV11-03+TCRBJ02-05	TCRBV11-03*01	TCRBD02-01*01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTACGACCTCGGACTTGACGGGGAGCTGTTTTTTGGAGAA	CASSYDLGLDGELFF	In	VDJ	5	166	0.00899728997289973	0.011618141097424413	45	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-02	01	4	1	10	7	8	3	18	31	44	39	47						01,02								CASSYDLGLDGELFF+TCRBV11-03+TCRBJ02-02	TCRBV11-03*01	TCRBD02-01	TCRBJ02-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGGAACGGACAGCTCAACACTGAAGCTTTCTTTGGACAA	CASRNGQLNTEAFF	In	VDJ	8	289	0.015663956639566396	0.02022676371780515	42	TCRBV11	TCRBV11-03	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	1	5	2	4	3	18	29	39	33	42														CASRNGQLNTEAFF+TCRBV11-03+TCRBJ01-01	TCRBV11-03*01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GACTCGGCCGTGTATGTCTGTGCCAGCAGCTCTCCGAGCTAGCCAAAAACATTCAGTACTTCGGCGCC		Out	VDJ	30	1067	0.0578319783197832		44	TCRBV11	TCRBV11-03	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-04	01	4	6	7	0	5	1	18	31	39	36	40						01,02								X+TCRBV11-03+TCRBJ02-04	TCRBV11-03*01	TCRBD02-01	TCRBJ02-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCTAGTGGTTTGGGCGGCACTGAAGCTTTCTTTGGACAA	CASGLGGTEAFF	In	VDJ	1	12	6.504065040650406E-4	8.398656215005599E-4	36	TCRBV12	TCRBV12-05	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	7	5	4	0	0	26	-1	-1	42	46						01,02								CASGLGGTEAFF+TCRBV12-05+TCRBJ01-01	TCRBV12-05*01	TCRBD02-01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCCGGACAGCGAACTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASRTANSGANVLTF	In	VDJ	1	29	0.0015718157181571816	0.0020296752519596865	45	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-06	01	12	1	5	0	5	4	26	31	42	36	46														CASRTANSGANVLTF+TCRBV12-05+TCRBJ02-06	TCRBV12-05*01	TCRBD01-01*01	TCRBJ02-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
AACCCAGGGACTCAGCTGTGTATTTTTGTGCCAGCTCTCGGTCCGGACACTTCATAGGCTACACCTTCGGTTCG	CASSRSGHFIGYTF	In	VDJ	2	62	0.0033604336043360434	0.004339305711086226	42	TCRBV12	TCRBV12-05	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	12	1	6	8	13	7	26	31	49	44	56														CASSRSGHFIGYTF+TCRBV12-05+TCRBJ01-02	TCRBV12-05*01	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTTAAAACGGACCCAGAGAGACCCAGTACTTCGGGCCA	CASS*NGPRETQYF	Stop	VDJ	1	13	7.046070460704607E-4		42	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-05	01	5	1	7	4	6	4	20	32	42	38	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASS*NGPRETQYF+TCRBV23-01+TCRBJ02-05	TCRBV23-01*01		TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGAACTTCTCGTTAATGAAAAACTGTTTTTTGGCAGT	CASSQELLVNEKLFF	In	VDJ	1	14	7.588075880758808E-4	9.798432250839866E-4	45	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-04	01	2	3	10	4	2	6	20	35	40	37	46						01,02								CASSQELLVNEKLFF+TCRBV23-01+TCRBJ01-04	TCRBV23-01*01	TCRBD02-01	TCRBJ01-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCAACGACAATGGTACAGGGAGGCTTTCTTTGGACAA	CASSQRQWYREAFF	In	VDJ	1	15	8.130081300813008E-4	0.0010498320268757	42	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	2	3	3	11	10	2	20	35	51	45	53														CASSQRQWYREAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTGGTCAGGGCGTACGAGCAGTACTTCGGGCCG	CASSLVRAYEQYF	In	VDJ	1	19	0.001029810298102981	0.0013297872340425532	39	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	4	3	4	6	2	20	31	42	37	44														CASSLVRAYEQYF+TCRBV23-01+TCRBJ02-07	TCRBV23-01*01	TCRBD01-01*01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCATGACAGGGTATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSMTGYSNQPQHF	In	VDJ	1	20	0.001084010840108401	0.0013997760358342665	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	6	2	3	0	3	2	20	31	41	34	43														CASSMTGYSNQPQHF+TCRBV23-01+TCRBJ01-05	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTGCCACTTATGAACACTGAAGCTTTCTTTGGACAA	CASSLPLMNTEAFF	In	VDJ	1	21	0.0011382113821138211	0.0014697648376259798	42	TCRBV23	TCRBV23-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	3	10	0	6	2	20	31	40	37	42						01,02								CASSLPLMNTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD02-01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGTCACGAGACAGGGGATTACTTCATGAACACTGAAGCTTTCTTTGGACAA	CASSHETGDYFMNTEAFF	In	VDJ	1	28	0.0015176151761517615	0.001959686450167973	54	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	3	2	2	0	3	9	20	34	45	37	54														CASSHETGDYFMNTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCTTATATCACAGGGGGTTCACTGAAGCTTTCTTTGGACAA	CASSLYHRGFTEAFF	In	VDJ	1	37	0.002005420054200542	0.002589585666293393	45	TCRBV23	TCRBV23-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	3	1	4	8	2	20	31	47	39	49														CASSLYHRGFTEAFF+TCRBV23-01+TCRBJ01-01	TCRBV23-01*01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
GAGACACGGCACTGTATCTCTGCGCCAGCAGCCAAGATAGGTTGCATGAGCAGTTCTTCGGGCCA	CASSQDRLHEQFF	In	VDJ	1	44	0.0023848238482384824	0.003079507278835386	39	TCRBV23	TCRBV23-01	01				TCRBJ02	TCRBJ02-01	01	2	5	4	8	3	4	20	35	41	38	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSQDRLHEQFF+TCRBV23-01+TCRBJ02-01	TCRBV23-01*01		TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCTAGCGGGGGGGCAACAGATACGCAGTATTTTGGCCCA	CASSPSGGATDTQYF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-03	01	5	4	0	3	1	2	23	35	48	36	50														CASSPSGGATDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGACTCGGAGCTCCTACGAGCAGTACTTCGGGCCG		Out	VDJ	1	10	5.420054200542005E-4		47	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-07	01	0	2	10	0	2	5	23	40	46	42	51						01,02								X+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD02-01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAATGAACAGGGGACGAACACCGGGGAGCTGTTTTTTGGAGAA	CASNEQGTNTGELFF	In	VDJ	1	11	5.962059620596206E-4	7.698768197088465E-4	45	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	3	2	0	4	1	23	33	44	37	45														CASNEQGTNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCAAACCCCCGGGAGAAATGGCTACACCTTCGGTTCG	CASSSQTPGRNGYTF	In	VDJ	1	11	5.962059620596206E-4	7.698768197088465E-4	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-02	01	4	8	2	6	10	2	23	36	52	46	54														CASSSQTPGRNGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01*02	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTTGGACAGGACGTTTGGCGAGCAGTACTTCGGGCCG	CASSLDRTFGEQYF	In	VDJ	1	11	5.962059620596206E-4	7.698768197088465E-4	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	4	6	1	8	23	36	44	37	52														CASSLDRTFGEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCTAGGACTAGCGGGTTTGGTGTGAGCAGTTCTTCGGGCCA		Out	VDJ	1	12	6.504065040650406E-4		49	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	1	4	9	3	7	23	38	52	41	59						01,02								X+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCACTAAGGGAGGGGACCTCTGGGGCCAACGTCCTGACTTTCGGGGCC	CASSPLREGTSGANVLTF	In	VDJ	1	13	7.046070460704607E-4	9.098544232922733E-4	54	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-06	01	5	9	0	0	7	3	23	35	49	42	52														CASSPLREGTSGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTGGGGGGGACTGGGGGAGACCCAGTACTTCGGGCCA	CASSWGGLGETQYF	In	VDJ	1	13	7.046070460704607E-4	9.098544232922733E-4	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-05	01	4	9	0	5	0	7	23	-1	43	36	50														CASSWGGLGETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGGGGGGTACACCGGGGAGCTGTTTTTTGGAGAA	CASGGYTGELFF	In	VDJ	1	13	7.046070460704607E-4	9.098544232922733E-4	36	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	8	9	1	3	0	1	23	-1	38	32	39														CASGGYTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCGCCCGGTGGGGGGCCAACGTCCTGACTTTCGGGGCC	CASARWGANVLTF	In	VDJ	1	15	8.130081300813008E-4	0.0010498320268757	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-06	01	8	8	5	4	3	3	23	32	38	35	41						01,02								CASARWGANVLTF+TCRBV06-08+TCRBJ02-06	TCRBV06-08*01	TCRBD02-01	TCRBJ02-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGGCCGGGACGGGCGAGGAGACCCAGTACTTCGGGCCA	CASSSAGTGEETQYF	In	VDJ	1	16	8.672086720867209E-4	0.0011198208286674132	45	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-05	01	4	0	7	5	5	7	23	36	46	41	53				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSSAGTGEETQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01		TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCATTCAGGGGGGACACACTGAAGCTTTCTTTGGACAA	CASSIQGGHTEAFF	In	VDJ	1	17	9.214092140921409E-4	0.0011898096304591265	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	6	4	1	3	4	3	23	34	45	38	48														CASSIQGGHTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCGCAGGGAGTCCTGGAAACACCATATATTTTGGAGAG	CASSAGSPGNTIYF	In	VDJ	1	17	9.214092140921409E-4	0.0011898096304591265	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-03	01	6	4	3	2	2	4	23	34	41	36	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSAGSPGNTIYF+TCRBV06-08+TCRBJ01-03	TCRBV06-08*01		TCRBJ01-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCTGGGACAGGGGGTGAAGCTTTCTTTGGACAA	CASSYSGTGGEAFF	In	VDJ	1	17	9.214092140921409E-4	0.0011898096304591265	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	0	0	1	7	1	0	23	40	-1	41	52														CASSYSGTGGEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACACCGACAGGGTGAATCATCCCACGAGCAGTACTTCGGGCCG	CASRHRQGESSHEQYF	In	VDJ	1	18	9.75609756097561E-4	0.0012597984322508398	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	2	3	5	5	11	23	34	46	39	57														CASRHRQGESSHEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAGACAGTGGATGGGATGAAAAACTGTTTTTTGGCAGT	CASRDSGWDEKLFF	In	VDJ	1	19	0.001029810298102981	0.0013297872340425532	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	2	5	6	1	8	23	34	40	35	48														CASRDSGWDEKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCAAGTGATAGCAATCAGCCCCAGCATTTTGGTGAT	CASSPSDSNQPQHF	In	VDJ	1	19	0.001029810298102981	0.0013297872340425532	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-05	01	6	2	8	0	7	0	23	34	-1	41	43				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSPSDSNQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01		TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCCCGAGGGGAACGAACTATGGCTACACCTTCGGTTCG		Out	VDJ	1	19	0.001029810298102981		44	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-02	01	4	5	2	2	4	4	23	36	45	40	49				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01		TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTACCAGCAACTCGGAACGCCGACAGGGCCAAGCTTTCTTTGGACAA	CTSNSERRQGQAFF	In	VDJ	1	20	0.001084010840108401	0.0013997760358342665	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	7	2	3	9	12	2	23	33	52	45	54														CTSNSERRQGQAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTCGACCCGGACAGGGAGTGGCACTGAAGCTTTCTTTGGACAA	CASSSTRTGSGTEAFF	In	VDJ	1	21	0.0011382113821138211	0.0014697648376259798	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	4	1	3	4	6	5	23	36	50	42	55														CASSSTRTGSGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGTCAGCAGATTTCAAATGGGGGATACGCAGTATTTTGGCCCA	CVSRFQMGDTQYF	In	VDJ	1	21	0.0011382113821138211	0.0014697648376259798	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-03	01	6	6	2	6	9	0	23	34	-1	43	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CVSRFQMGDTQYF+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01		TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCACAAACAGGGACTATGCGAATCAGCCCCAGCATTTTGGTGAT	CATNRDYANQPQHF	In	VDJ	1	26	0.0014092140921409214	0.0018197088465845466	42	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-05	01	10	0	9	4	6	4	23	30	43	36	47						01,02								CATNRDYANQPQHF+TCRBV06-08+TCRBJ01-05	TCRBV06-08*01	TCRBD02-01	TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCGACTGAGGACACTGAAGCTTTCTTTGGACAA	CASSPTEDTEAFF	In	VDJ	1	28	0.0015176151761517615	0.001959686450167973	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	5	2	10	3	2	4	23	35	41	37	45						01,02								CASSPTEDTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGAAAGACAGGGATGGAAGGTGGCTACACCTTCGGTTCG	CASRKTGMEGGYTF	In	VDJ	1	34	0.0018428184281842818	0.002379619260918253	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	2	3	7	3	8	23	34	44	37	52														CASRKTGMEGGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCGGGCCAGAGGGCTATGGCTACACCTTCGGTTCG		Out	VDJ	1	34	0.0018428184281842818		41	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-02	01	5	7	4	4	0	8	23	-1	40	35	48						01,02								X+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD02-01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTACCCTGAGGGGGCGGGCGAACACTGAAGCTTTCTTTGGACAA	CASSTLRGRANTEAFF	In	VDJ	1	36	0.001951219512195122	0.0025195968645016797	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-01	01	5	5	0	1	6	4	23	35	48	41	52														CASSTLRGRANTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACACCCGGTTCTCCTACAATGAGCAGTTCTTCGGGCCA	CASSYTRFSYNEQFF	In	VDJ	1	37	0.002005420054200542	0.002589585666293393	45	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ02	TCRBJ02-01	01	2	8	5	0	3	2	23	38	44	41	46						01,02								CASSYTRFSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACCCAGGGGATAGAATTCACCCCTCCACTTTGGGAAC		Out	VDJ	1	37	0.002005420054200542		44	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	2	4	2	7	1	4	23	38	45	39	49														X+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGTGGGGCCACCCAGTACTTCGGGCCA	CASSYSSGATQYF	In	VDJ	1	38	0.002059620596205962	0.0026595744680851063	39	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	0	7	0	8	4	1	23	40	49	44	50														CASSYSSGATQYF+TCRBV06-08+TCRBJ02-05	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCATTAGTGGGGCGAGTCGTAACACCGGGGAGCTGTTTTTTGGAGAA	CASISGASRNTGELFF	In	VDJ	1	38	0.002059620596205962	0.0026595744680851063	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-02	01	7	7	0	2	5	7	23	33	43	38	50														CASISGASRNTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGAGAGCGCGGGGGGGACTAAATGAGCAGTTCTTCGGGCCA	CASSYSRARGGLNEQFF	In	VDJ	1	42	0.0022764227642276423	0.0029395296752519596	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	0	7	0	7	6	4	23	40	55	46	59														CASSYSRARGGLNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTCCAGGGGCGGTGGATTATGGCTACACCTTCGGTTCG	CASSPGAVDYGYTF	In	VDJ	1	43	0.0023306233062330623	0.003009518477043673	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	5	4	2	5	1	8	23	35	42	36	50														CASSPGAVDYGYTF+TCRBV06-08+TCRBJ01-02	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGAATGGGAGGGGGGCGCCGAATCAGATACGCAGTATTTTGGCCCA		Out	VDJ	1	44	0.0023848238482384824		46	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	02	TCRBJ02	TCRBJ02-03	01	9	9	0	4	3	11	23	31	41	34	52														X+TCRBV06-08+TCRBJ02-03	TCRBV06-08*01	TCRBD02-01*02	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGGCCGGACGCGGACTGAAGCTTTCTTTGGACAA	CASSGRTRTEAFF	In	VDJ	1	52	0.002818428184281843	0.003639417693169093	39	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	5	1	7	5	4	4	23	35	43	39	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSGRTRTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGACTTTACAGGGGGAAACACGGCTAATGAAAAACTGTTTTTTGGCAGT		Out	VDJ	1	53	0.002872628726287263		52	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	6	3	1	3	5	8	23	34	47	39	55														X+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGGCCCCTAGCGGGGGGGCCTCTCACCGGGGAGCTGTTTTTTGGAGAA	CASRPLAGGPLTGELFF	In	VDJ	2	58	0.003143631436314363	0.004059350503919373	51	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-02	01	6	4	0	4	4	5	23	34	50	38	55														CASRPLAGGPLTGELFF+TCRBV06-08+TCRBJ02-02	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCATGGCCCAAGGGGACGCCTACGAGCAGTACTTCGGGCCG	CAMAQGDAYEQYF	In	VDJ	2	59	0.003197831978319783	0.004129339305711086	39	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-07	01	10	0	7	2	9	1	23	30	44	39	45				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CAMAQGDAYEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01		TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGACAGGGTTTCACCCCTCCACTTTGGGAAC	CASSDRVSPLHF	In	VDJ	2	68	0.0036856368563685637	0.004759238521836506	36	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-06	01	5	2	3	9	0	1	23	-1	42	35	43														CASSDRVSPLHF+TCRBV06-08+TCRBJ01-06	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-06*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATCTTACGCCTCCCAACAGGGAAAAACTGTTTTTTGGCAGT	CASSYLTPPNREKLFF	In	VDJ	2	73	0.003956639566395664	0.005109182530795073	48	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-04	01	3	3	4	8	14	0	23	37	-1	51	56														CASSYLTPPNREKLFF+TCRBV06-08+TCRBJ01-04	TCRBV06-08*01	TCRBD01-01*01	TCRBJ01-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCCCCCGATGGGGGCTCCACGAGCAGTACTTCGGGCCG	CASSPRWGLHEQYF	In	VDJ	2	86	0.004661246612466125	0.006019036954087346	42	TCRBV06	TCRBV06-08	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	6	6	0	5	8	3	23	34	48	42	51														CASSPRWGLHEQYF+TCRBV06-08+TCRBJ02-07	TCRBV06-08*01	TCRBD01-01*01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTACTCGGGGAACTACAATGAGCAGTTCTTCGGGCCA	CASSYSGNYNEQFF	In	VDJ	4	131	0.0071002710027100275	0.009168533034714446	42	TCRBV06	TCRBV06-08	01				TCRBJ02	TCRBJ02-01	01	0	0	8	3	1	1	23	40	45	41	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGNYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01		TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGCTACTTGAGCGGCACTGAAGCTTTCTTTGGACAA	CASSYLSGTEAFF	In	VDJ	4	154	0.00834688346883469	0.010778275475923853	39	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	1	6	5	4	2	0	23	39	-1	41	46						01,02								CASSYLSGTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01	TCRBD02-01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTGCTGCCCGGGGGGGATCCTACAATGAGCAGTTCTTCGGGCCA	CASSAARGGSYNEQFF	In	VDJ	4	154	0.00834688346883469	0.010778275475923853	48	TCRBV06	TCRBV06-08	01	TCRBD02	TCRBD02-01	01	TCRBJ02	TCRBJ02-01	01	5	8	0	1	6	1	23	35	49	41	50														CASSAARGGSYNEQFF+TCRBV06-08+TCRBJ02-01	TCRBV06-08*01	TCRBD02-01*01	TCRBJ02-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CCTCCCAGACATCTGTGTACTTGTGTGCCAGCAGTTATTCGGGCAGCAACACTGAAGCTTTCTTTGGACAA	CASSYSGSNTEAFF	In	VDJ	8	273	0.014796747967479675	0.019106942889137737	42	TCRBV06	TCRBV06-08	01				TCRBJ01	TCRBJ01-01	01	3	8	0	2	3	3	23	37	44	40	47				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01									CASSYSGSNTEAFF+TCRBV06-08+TCRBJ01-01	TCRBV06-08*01		TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCGACGGCCGGGGGCAACATTCAGTACTTCGGCGCC	CASSPTAGGNIQYF	In	VDJ	1	10	5.420054200542005E-4	6.998880179171332E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-04	01	3	6	0	7	7	0	24	38	-1	45	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPTAGGNIQYF+TCRBV18-01+TCRBJ02-04	TCRBV18-01*01		TCRBJ02-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCACAGGGGACGCAACAGCCCCAGCATTTTGGTGAT	CASSSQGTQQPQHF	In	VDJ	1	11	5.962059620596206E-4	7.698768197088465E-4	42	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-05	01	1	0	7	7	2	4	24	40	47	42	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSSQGTQQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01		TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACGACAGGACAATCAGCCCCAGCATTTTGGTGAT	CASSRQDNQPQHF	In	VDJ	1	12	6.504065040650406E-4	8.398656215005599E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-05	01	4	2	4	3	0	1	24	-1	43	37	44													Vb 18	CASSRQDNQPQHF+TCRBV18-01+TCRBJ01-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCAGCCGGGACCCGAGAGAATGAAAAACTGTTTTTTGGCAGT	CASSAGTRENEKLFF	In	VDJ	1	14	7.588075880758808E-4	9.798432250839866E-4	45	TCRBV18	TCRBV18-01	01				TCRBJ01	TCRBJ01-04	01	5	0	7	5	3	7	24	36	44	39	51				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSAGTRENEKLFF+TCRBV18-01+TCRBJ01-04	TCRBV18-01*01		TCRBJ01-04*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATCGGGAGGGGGGAACACTGAAGCTTTCTTTGGACAA	CASSSGGGNTEAFF	In	VDJ	1	14	7.588075880758808E-4	9.798432250839866E-4	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01	02	TCRBJ01	TCRBJ01-01	01	5	8	0	1	1	2	24	36	45	37	47													Vb 18	CASSSGGGNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01*02	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTCCCGGACAGGGGGAAACCCAGTACTTCGGGCCA	CASSPGQGETQYF	In	VDJ	1	14	7.588075880758808E-4	9.798432250839866E-4	39	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-05	01	6	1	1	8	4	2	24	35	49	39	51													Vb 18	CASSPGQGETQYF+TCRBV18-01+TCRBJ02-05	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-05*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCCTTCGGCACGAGCAGTACTTCGGGCCG	CASSPLRHEQYF	In	VDJ	1	20	0.001084010840108401	0.0013997760358342665	36	TCRBV18	TCRBV18-01	01				TCRBJ02	TCRBJ02-07	01	3	9	0	5	5	0	24	38	-1	43	46				TCRBD01,TCRBD02	TCRBD01-01,TCRBD02-01								Vb 18	CASSPLRHEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01		TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACTAGGACAGGACCAACCCTACGAGCAGTACTTCGGGCCG	CASSLGQDQPYEQYF	In	VDJ	1	24	0.0013008130081300813	0.0016797312430011197	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	4	1	4	2	2	6	24	37	46	39	52													Vb 18	CASSLGQDQPYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCTCCGACTGTTGGATTGGCTTTCTTTGGACAA	CASSPTVGLAFF	In	VDJ	1	29	0.0015718157181571816	0.0020296752519596865	36	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	2	10	11	3	9	24	35	42	38	51						01,02							Vb 18	CASSPTVGLAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCCCGAACTCGATCGAACACTGAAGCTTTCTTTGGACAA	CASSRTRSNTEAFF	In	VDJ	1	34	0.0018428184281842818	0.002379619260918253	42	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	6	3	10	1	4	5	24	35	42	39	47						01,02							Vb 18	CASSRTRSNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGGGGGACAGGGGGAGTTATGGCTACACCTTCGGTTCG	CASSGDRGSYGYTF	In	VDJ	1	34	0.0018428184281842818	0.002379619260918253	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-02	01	6	0	1	5	2	3	24	35	48	37	51													Vb 18	CASSGDRGSYGYTF+TCRBV18-01+TCRBJ01-02	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-02*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCCGGGTTGATAAGATCGATGAACACTGAAGCTTTCTTTGGACAA	CASSPGLIRSMNTEAFF	In	VDJ	1	40	0.002168021680216802	0.002799552071668533	51	TCRBV18	TCRBV18-01	01	TCRBD02	TCRBD02-01		TCRBJ01	TCRBJ01-01	01	3	8	4	0	0	13	24	-1	42	38	55						01,02							Vb 18	CASSPGLIRSMNTEAFF+TCRBV18-01+TCRBJ01-01	TCRBV18-01*01	TCRBD02-01	TCRBJ01-01*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCGAACAGGGTCCTTTCTGGAAACACCATATATTTTGGAGAG	CASSNRVLSGNTIYF	In	VDJ	1	43	0.0023306233062330623	0.003009518477043673	45	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ01	TCRBJ01-03	01	6	3	3	1	2	5	24	35	43	37	48													Vb 18	CASSNRVLSGNTIYF+TCRBV18-01+TCRBJ01-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ01-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCACCAGATCAGGGGCCCTACGAGCAGTACTTCGGGCCG	CASSPDQGPYEQYF	In	VDJ	1	49	0.0026558265582655827	0.0034294512877939528	42	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-07	01	2	4	2	2	3	1	24	39	48	42	49													Vb 18	CASSPDQGPYEQYF+TCRBV18-01+TCRBJ02-07	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-07*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
CGAGGAGATTCGGCAGCTTATTTCTGTGCCAGCTCATGAGGGGGCGAGCACAGATACGCAGTATTTTGGCCCA		Out	VDJ	7	234	0.012682926829268294		43	TCRBV18	TCRBV18-01	01	TCRBD01	TCRBD01-01	01	TCRBJ02	TCRBJ02-03	01	5	5	0	0	2	1	24	36	45	38	46													Vb 18	X+TCRBV18-01+TCRBJ02-03	TCRBV18-01*01	TCRBD01-01*01	TCRBJ02-03*01	5441A	Human	TCRB	Survey		ISS10006	immunoSEQ hsTCRB-FFPE Service (Survey)	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor				662	512	140	8	0	478	385	84	9	0	18450	14288	3922	240	0	0.0800021216	7.90159941	0.0905349702	8.09502697				2590	0.198337212	0.0612402	0.0578319766	v2	Human-TCRB-PD2x	Published	09/16/2016 03:39:39	09/06/2016 10:38:25	Age (Range):24-45 Years (Middle Adulthood),Age:40 Years,Cancer:Ovarian Cancer,Preservation Type:FFPE,Species:Human,Tissue Source:Ovary,Tissue Source:Tissue,Tissue Source:Tumor,os censored status:os censored status 0,overall survival (days):overall survival (days) 1511,pfs censored status:pfs censored status 1,progression free survival (days):progression free survival (days) 997,type of chemo:carbo/taxol	0.7734138762004715	MSKCC- Snyder- P01-02		514.0	
